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The number of different hypotheses erected to explain a given biological phenomenon is 
inversely proportional to the available knowledge.  
                                                                                      
 
 
                   Eddington's Theory 
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ABBREVIATIONS AND NOMENCLATURE 
 
 
ADP-ribose  adenosine 5?-diphosphoribose sodium salt 
DDM    n-dodecyl ?-D-maltopyranoside 
DMSO                dimethyl sulfoxide 
dNADH   nicotinamide hypoxanthine dinucleotide reduced sodium salt 
DQ   decylubiquinone 
??   electric membrane potential 
??H+    electrochemical proton gradient across the membrane 
EPR    electron paramagnetic resonance 
FAD                    flavin adenine dinucleotide 
FeCy    ferricyanide 
FMN                   flavin mononucleotide 
HAR    hexaammineruthenium (III) chloride 
HEPES   4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
IC50                              half maximal inhibitory concentration 
Km    Michaelis-Menten constant 
LB   Luria-Bertani broth 
MES     2-(N-morpholino)ethanesulfonic acid 
NAD  ??-nicotinamide adenine dinucleotide sodium salt from yeast 
NADH  ??-nicotinamide adenine dinucleotide reduced disodium salt 
NDH-I   NADH dehydrogenase Type-I (proton-pumping NADH:ubiquinone     
                            oxidoreductase) 
NDH-II   NADH dehydrogenase Type-II (non-proton-pumping 
NADH:ubiquinone oxidoreductase) 
N-side     negatively charged side of the (inner mitochondrial or bacterial)   
membrane 
P-side    positively charged side of the (inner mitochondrial or bacterial) 
membrane 
pKa   a logarithmic measure of the acid dissociation constant 
Q   ubiquinone 
ROS    reactive oxygen species 
SDS-PAGE   sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Tris/HCl  Tris (hydroxymethyl)aminomethane hydrochloride 
 
 
 
The amino acid numbering and subunit nomenclature are given for Escherichia coli 
Complex I, if not mentioned otherwise. 
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1. INTRODUCTION 
Life on our planet is powered by the energy of sunlight. Phototrophs, plants, algae 
and cyanobacteria, absorb it directly and convert it into the energy of chemical bonds 
during photosynthesis. In this complex stepwise process, photon energy is used for 
electron transfer from water to carbon dioxide, which results in the formation of 
energy-rich carbohydrates, mainly glucose, sucrose and starch, and the release of 
molecular oxygen. Photosynthesis is one of the most important biochemical processes in 
the biosphere, since it conserves solar energy in the form of organic matter. Living cells 
have a number of powerful catabolic pathways for the conversion of energy from this 
store into a primary metabolically usable form, namely a transmembrane proton 
electrochemical gradient. The energy released upon the controlled flow of protons down 
their electrochemical gradient is used for many energy-consuming processes, such as 
active transport of molecules across the membrane and production of ATP, the main 
energy intermediate in the cell.  
Utilization of food molecules in order to form the electrochemical proton gradient is 
referred to as cellular respiration. This process of energy conversion starts from stepwise 
dehydrogenation of sugars, fatty acids and proteins in correspondent catabolic pathways 
accompanied by simultaneous reduction of several intermediate electron carriers in the 
cell, such as NAD+ to NADH, quinone to quinol, and release of carbon dioxide as a final 
product of the disintegration of nutrients.  Further, the electrons from these electron 
donors are transferred through the respiratory or electron transport chain, consisting of 
a series of transmembrane proteins, to a final electron acceptor, such as molecular oxygen. 
This multi-step redox reaction releasing free energy is coupled with a vectorial proton 
transfer across the membrane by the respiratory enzymes. In this way the proton 
electrochemical gradient, ??H+, is formed.  
This concept of energy conservation in the form of a proton gradient across the 
membrane was proposed by Peter Mitchell in 1961 in his chemiosmotic theory and 
nowadays has become the paradigm in bioenergetics (Mitchell, 1961). 
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1.1. The respiratory chain of eukaryotes 
The respiratory chain of eukaryotes is located in mitochondria and in most  cases 
consists of  four multisubunit enzymes embedded into the inner mitochondrial membrane 
and ubiquinone and cytochrome c (see for review (Saraste, 1999)) (Fig. 1). The electron 
passage from NADH to oxygen starts from the NADH:ubiquinone oxidoreductase or 
Complex I.  This enzyme catalyzes the transfer of two electrons from NADH to 
ubiquinone and utilizes free energy released in this redox reaction for the translocation of 
four protons across the membrane, from the matrix to the intermembrane space (from the 
N-side to the P-side of the membrane). Hence Complex I serves as a proton pump with 
an H+/2e? stoichiometry of 4. So far the mechanism of energy transduction by Complex 
I is unknown. It should also be noted, that some aerobic organisms, such as yeast 
Saccharomyces cerevisiae, have instead of Complex I an alternative NADH 
dehydrogenase, which also reduces ubiquinone, but does not contribute to formation of 
??H+ (Joseph-Horne et al., 2001). Ubiquinone can also be reduced by another respiratory 
enzyme, succinate dehydrogenase or Complex II, which serves as a ‘funnel’ for the 
electrons into the respiratory chain. Complex II accepts electrons from succinate, an 
intermediate product of the Krebs cycle, and transfers them to ubiquinone without 
coupling this reaction with proton translocation across the membrane (see for reviews 
(Cecchini, 2003; Horsefield et al., 2004)). Ubiquinone reduced by Complex I or Complex 
II donates electrons to the ubiquinol:cytochrome c oxidoreductase (bc1 complex) or 
Complex III, which utilizes them for the reduction of cytochrome c. Complex III 
contributes to formation of ??H+  and works as a Q-loop. This means that a proton uptake 
from the N-side and its release on the P-side is based on the redox chemistry of quinone, 
but  not  on  direct  translocation  of  a  proton  across  the  membrane  part  of  the  protein.  
Complex III has two quinone-binding sites located on opposite sides of the membrane. 
Oxidation of quinol accompanied by a release of two protons takes place on the P-side 
of the membrane. Complex III splits two electrons accepted from one quinol molecule. 
One of these electrons is used for the reduction of a molecule of water-soluble 
one-electron carrier cytochrome c, and another is transferred through cofactors of the 
enzyme to the opposite site of the membrane where it is used for the reduction of another 
molecule of quinone to semiquinone.  
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Figure 1. Schematic representation of the mitochondrial respiratory chain and ATP syntase. The 
picture is based on the 3D-structures 2FUG, 1YQ3, 1BGY, 2B4Z, 1QLE, 1BMF, 1YCE. The 
image of the hydrophobic domain of Complex I comes from the electron microscopy images of the 
intact enzyme from N. crassa (Guenebaut, 1997). Ubiquinone is depicted as an orange circle.  
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Oxidation of the next molecule of quinol on the P-side provides a second electron to 
complete the reduction of semiquinone with simultaneous uptake of two protons from the 
N-side of the membrane. Thus, proton translocation by Complex III is based on vectorial 
chemistry and has a stoichiometry of 2H+/2e? (for reviews see (Crofts, 2004; Osyczka et 
al., 2005)). The reduced cytochrome c donates an electron to the last enzyme in the 
respiratory chain, cytochrome c oxidase or Complex IV, which then reduces the final 
electron acceptor, molecular oxygen, into water.  Cytochrome c oxidase  works  as  a  
proton pump since it translocates two protons across the membrane per electron accepted 
from cytochrome c (reviewed in (Wikström and Verkhovsky, 2006;  Zaslavsky and 
Gennis, 2000). The redox-driven proton transfer by complexes I, III and IV generates the 
electrochemical proton gradient across the membrane, which has two components: 
electrical, ??, and osmotic, ?pH. In mitochondria the energy stored in the form of an 
electrochemical proton gradient is used presumably by ATP synthase for ATP synthesis 
from ADP and inorganic phosphate (for the review Walker and Dickson, 2006). This 
process is known as oxidative phosphorylation. ATP serves as the molecular ‘currency’ 
of the energy in the cell. However, one has to keep in mind that ATP hydrolysis is 
accompanied by the release of free energy only because the living cell keeps the 
mass–action ratio between the substrate, ATP, and products, ADP and phosphate, shifted 
by several orders of magnitude from the equilibrium through constant synthesis of ATP 
(Nicholls, 1992). Although some fraction of ATP is available from substate-level 
phosphorylation (for example, in glycolysis), the energy for the synthesis of the major 
fraction is produced by the respiratory chain.  
1.2. The respiratory chain of prokaryotes  
 In prokaryotes the respiratory chain is located in the cytoplasmic membrane. The 
main difference between mitochondrial and bacterial respiratory chains is that the latter is 
branched, variable and inducible by growth conditions. Bacteria have a wide diversity of 
the membrane-bound dehydrogenases through which electrons can enter the respiratory 
chain (Anraku, 1988; Ingledew and Poole, 1984). For example, under aerobic conditions 
they could be: NADH:ubiquinone oxidoreductase and succinate dehydrogenase, 
counterparts of mitochondrial Complex I and Complex II; lactate dehydrogenase, 
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glycerophosphate dehydrogenase. All mentioned dehydrogenases reduce the membrane 
quinone pool, but only Complex I contributes to the formation of ??H+.  Quinol  is  a  
crossroad for the electron flux in bacterial respiratory chains, because it can be oxidized 
not only by an analog of mitochondrial bc1 complex  (Complex  III),  but  also  by  the  
enzymes catalyzing the final electron transfer step. Under aerobic conditions these are 
terminal oxidases, which catalyse reduction of oxygen to water. Under anaerobic 
conditions a bacterial cell utilizes other final electron acceptors, such as dimethyl 
sulfoxide, fumarate, trimethylamine N-oxide, nitrite or nitrate, which are reduced by the 
enzymes designated as terminal reductases (Anraku, 1988;  Ingledew and Poole, 1984).  
 The present work focuses on the study of Complex I. Since the enzyme used for 
the research was isolated from aerobically grown Escherichia coli cells, it is worth 
describing the organization of the respiratory chain of this bacterium in more detail. The 
oxygen-dependent respiratory chain of E. coli has two distinct NADH:ubiquinone 
oxidoreductases: NDH-I or Complex I and NDH-II or NADH dehydrogenase type-II 
(Calhoun and Gennis, 1993; Matsushita et al., 1987). NDH-II consists of one polypeptide 
with  noncovalently  bound  FAD  as  a  redox  cofactor  (Jaworowski et al., 1981a;  
Jaworowski et al., 1981b). This enzyme catalyses ubiquinone reduction but does not 
couple this reaction to proton translocation. Electrons can also enter the respiratory chain 
of E. coli through Complex II or succinate:ubiquinone oxidoreductase, which consists of 
four subunits containing five redox groups: covalently bound FAD, three Fe-S clusters 
and  B-type heme (Kita et al., 1989). The respiratory chain of E. coli is simplified because 
of the absence of an analog of mitochondrial bc1 complex or Complex III (Ingledew and 
Poole, 1984). The reduced ubiquinone donates the electrons directly to an oxidase 
catalyzing reduction of oxygen to water. E. coli has two types of terminal oxidases, 
namely cytochrome bd quinol oxidase and cytochrome bo3 quinol oxidase, which have 
different affinities to oxygen (Ingledew and Poole, 1984). Under high tension of oxygen 
presumably bo3 quinol oxidase is expressed, which works as a proton pump with a 
stoichiometry of 2H+/e?. This enzyme consists of four polypeptides and contains copper 
(CuB),  B-type low-spin heme and  O-type high-spin heme, the latter of which reacts with 
oxygen (Matsushita et  al., 1983; Salerno et al., 1990). Under low concentration of 
oxygen in the medium bd quinol oxidase is expressed. This enzyme consists of two 
subunits and has B- and D-type high-spin hemes in addition to B-type low-spin heme, 
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which accepts electrons from quinol (Green et al., 1986; Miller and Gennis, 1983). The 
bd quinol oxidase has a higher affinity to oxygen than bo3 type oxidase, but does not 
pump protons (Miller and Gennis, 1985; Puustinen et al., 1991), though it contributes to 
the generation of an electrochemical proton gradient due to the operation of the 
redox-loop mechanism.  
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2. THE STRUCTURE AND FUNCTION OF COMPLEX I 
 Complex I is the first member in the respiratory chain of mitochondria and many 
aerobic bacteria. The enzyme catalyses the transfer of two electrons from NADH to 
ubiquinone coupled with the translocation of four protons across the membrane, from the 
matrix side of mitochondria or cytoplasm of bacteria (negative side of the membrane) to 
the intermembrane space or bacterial periplasm (positive side of the membrane). This 
reaction contributes to the formation of the proton motive force generated by the 
respiratory chain. The overall reaction catalyzed by Complex I can be described by the 
following equation: 
 
NADH(N-side) + H+ + Q + 4H+(N-side)?  NAD+(N-side) + QH2 + 4H+(P-side)  
2.1. The overall structure of Complex I 
Complex I is the largest and the most complicated of all respiratory enzymes. In 
mammalian mitochondria the enzyme is composed of 45 different subunits with a total 
molecular mass of 980 kDa (Carroll et  al.,  2006).  In  contrast  bacterial  Complex  I  or  
NDH-1 is two times smaller in size and has 13-14 subunits with a total mass of approx. 
550 kDa, but what is important, all of them have counterparts in mitochondrial enzyme 
(Friedrich et al., 1995; Leif et al., 1993; Leif et al., 1995; Yagi et al., 1998). Seven of 
these subunits are highly hydrophobic and in eukaryotes they are encoded by mitochon-
drial genome (Weidner et al., 1993). Another seven subunits are hydrophilic and contain 
all redox groups of Complex I, namely the flavin and a number of iron-sulfur clusters 
(Finel et  al., 1992; Wang et  al., 1991;  Weiss et  al., 1991) (Table 1). In eukaryotes 
hydrophilic subunits are nuclear encoded (Carroll et al., 2002;  Hirst et al., 2003). Thus, 
in both mitochondrial and bacterial Complex I the catalytic core is composed of 14 
‘minimal’ subunits which are sufficient for energy transduction (Leif et al., 1993). The 
remaining up to 31 subunits in eukaryotic Complex I are called additional or accessory 
and encoded by the nucleus (Carroll et al., 2006;   Fearnley et al., 2007). Their function 
is not yet clear. In bovine enzyme, 14 of accessory subunits, classified as single 
transmembrane domain proteins, are probably needed for assembly of the membrane 
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subunits of Complex I and the stability of the enzyme (Abdrakhmanova et al., 2004). In 
the yeast Y. lipolytica one of the accessory subunits tightly binds NADPH, which is 
needed for the stability of the enzyme (Abdrakhmanova et al., 2006). In addition, for 
several subunits a regulatory role has been proposed (Fearnley et al., 2001;  Papa et al., 
2002). 
Single particle analysis of Complex I isolated from a number of eukaryotic 
(Guenebaut et al., 1997;  Djafarzadeh et al., 2000; Grigorieff, 1998; Sazanov and Walker, 
2000;  Zickermann et al., 2003) and prokaryotic (Peng et al., 2003; Sazanov et al., 2003) 
sources revealed the unusual L-shape structure of the enzyme, which is composed of two 
nearly perpendicular standing domains, one hydrophilic and another hydrophobic. The 
former one contains all redox cofactors and protrudes into the mitochondrial matrix or 
cytoplasm in bacteria. The latter one is embedded into the membrane. It was noted that 
the particle size of a bacterial enzyme is smaller in comparison to that of the mitochondrial 
enzyme due to the absence of additional subunits (Guenebaut et al., 1998). 
Since Complex I from bacteria and Complex I from mitochondria are structurally 
and functionally similar in terms of catalytic core and contain equivalent redox groups, the 
bacterial Complex I with its 14 subunits is considered a useful simple model for 
structure-functional studies of mitochondrial enzyme.  
Complex I has been under investigation for more than 40 years (Hatefi et al., 
1962). For a long time bovine heart mitochondria or the fungus Neurospora crassa were 
used as a source for purification of mitochondrial enzyme. Recently, the yeast Yarrowia 
lipolytica was introduced as a model organism in studies of eukaryotic Complex I 
(Kerscher et al., 2002). Complex I is present in bacteria, for example, in Escherichia coli, 
Thermus thermophilus, Paraccocus denitrificans and Rhodobacter capsulatus (Yagi et 
al., 1998). The advantage of bacterial systems for studying Complex I is the relative 
simplicity of genetic manipulation of prokaryotes. However, the main obstacle in studies 
of the most bacterial NDH-I is the instability of the protein upon solubilization with 
detergent (Dupuis et al., 1995; Herter et al., 1997; Yagi, 1986).  
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Table 1 
Central subunits of Complex I (NDH-I in bacteria) 
Bovine 
Complex 
I 
P. 
denitrificans 
and 
T. 
thermophilus 
NDH-I 
E. coli 
and 
R. 
capsulatus 
NDH-I 
Domain Sub- complex Cofactors 
Names 
of 
Fe-S 
centers 
51-kDa Nqo1 NuoF 
FMN 
[4Fe-4S] 
 
N3 
24-kDa Nqo2 NuoE [2Fe-2S] N1a 
75-kDa Nqo3 NuoG 
DF 
[2Fe-2S] 
??[4Fe-4S] 
[4Fe-4S] 
N1b 
N4, N5 
N7b 
49-kDa Nqo4 NuoD?   
30-kDa Nqo5 NuoC?   
PSST Nqo6 NuoB [4Fe-4S] N2 
TYKY Nqo9 NuoI 
Hydrophilic 
domain 
CF 
??[4Fe-4S] N6a, N6b 
ND1 Nqo8 NuoH 
ND2 Nqo14 NuoN 
ND3 Nqo7 NuoA 
ND4 Nqo13 NuoM 
ND4L Nqo11 NuoK 
ND5 Nqo12 NuoL 
ND6 Nqo10 NuoJ 
Hydrophobic 
domain 
MF    
?In some bacteria, NuoC and D are fused, b this cluster present only in some bacteria 
Abbreviations: DF, dehydrogenase fragment; CF, connecting fragment; MF, membrane 
fragment  
 
So far the intact bacterial enzyme has been purified only from Escherichia coli 
(David et al., 2002; Holt et al., 2003; Leif et al., 1995) (Paper I, II), the closely related 
Klebsiella pneumoniae (Krebs et  al., 1999), and the extreme thermophile Aquifex 
aeolicus (Peng et al., 2003), while in other bacteria Complex I has been studied in situ (Di 
Bernardo and Yagi, 2001; Kao et al., 2004b), or in fragments (Sazanov and Hinchliffe, 
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2006). Although all studied prokaryotic and eukaryotic forms of Complex I have similar 
core subunits, there is no unified nomenclature established for them. In mitochondrial 
enzyme hydrophilic nuclear encoded subunits are named according to their molecular 
masses while hydrophobic mitochondrial DNA-encoded subunits are named ‘ND’ with a 
corresponding number. Subunits of bacterial NDH-I from Paracoccus denitrificans and 
Thermus thermophilus are named as Nqo, from Escherichia coli and Rhodobacter 
sphaeroides – as Nuo (Table 1). 
 It  is  worth  noting  that  structure-functional  studies  of  Complex  I  also  have  
medical importance since numerous neurodegenerative disorders in humans, such as 
Lebers Hereditary Optic Neuropathy (LHON), Leigh syndrome and Parkinson’s disease, 
are associated with mutations in Complex I or its deficiency (Robinson, 1998; Loeffen et 
al., 2000; Triepels et al., 2001). Pathogenic mutations in Complex I have been found in 
all fourteen “core” subunits as well as in accessory nuclear encoded subunits (Lebon et 
al., 2003; Lebon et al., 2007; Loeffen et al., 1998; Martin et al., 2005; McFarland et al., 
2004; Ugalde et al., 2007; van del Heuvel et al., 1998; Petruzzella and Papa, 2002). 
2.1.1. The hydrophilic domain  
 The NDH-I from E. coli is commonly used as a minimal model to study Complex 
I. The genes encoding all subunits of E. coli Complex I named nuoA-N are organized in 
the nuo operon (Weidner et al., 1993). The same order of genes is found in other species 
of bacteria (Friedrich et al., 1995; Weidner et al., 1993; Xu et al., 1993). It should also 
be noted that in E. coli Complex I two genes — nuoC and nuoD — are fused (Blattner 
et al., 1997; Braun et al., 1998), which results in a 13 subunit enzyme. Anyhow, this 
fusion has been found only in a few bacterial species.  
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Figure 2. A. The overall structure of the catalytic core of Complex I. The picture was prepared 
based on the crystal structure of the hydrophilic domain of T. thermophilus Complex I (Protein 
Data Bank entry 2FUG (Sazanov and Hinchliffe, 2006)). The arrangement of subunits within the 
hydrophobic domain is based on currently available data (see text). Subunits are marked 
according to E. coli nomenclature except for the subunit Nqo15, the presence of which could be 
specific only for thermophiles. The yellow transparent circle marks the place of the tentative 
quinone-binding site.  B. Arrangement of redox groups within the hydrophilic domain. 
Edge-to-edge distances are given in Å. The picture was prepared using VMD molecular 
visualization software (Humphrey et al., 1996).  
 
The hydrophilic domain of E. coli Complex I is composed of six subunits, namely 
NuoE, NuoF, NuoG, NuoCD, NuoI and NuoB, which contain all redox groups of the 
enzyme (Table 1). Recently, the 3D crystal structure of this domain from T. thermophilus 
enzyme has been resolved by X-ray analysis (Sazanov and Hinchliffe, 2006) (Fig. 2A). 
The resolved structure shows the arrangement of the core subunits within the hydrophilic 
domain and redox groups that they contain. The iron-sulfur clusters form an in-
tramolecular electron transport chain, which spans through the whole length of the 
hydrophilic domain and provides a pathway for the electron transfer from the flavin, 
located on the top of the peripheral arm to the ubiquinone bound in the membrane domain 
of the enzyme. Thus, the function of the hydrophilic domain is the oxidation of the NADH 
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and electron delivery to the quinone-binding site. It should also be noted that the crystal 
structure revealed the presence of an additional subunit in the hydrophilic arm of T. 
thermophilus Complex I (Hinchliffe et al., 2006; Sazanov and Hinchliffe, 2006). This new 
subunit was designated as Nqo15, according to T. thermophilus nomenclature. Although 
Nqo15 interacts with subunits Nqo3, Nqo2, Nqo1, Nqo9 and Nqo4 (NuoG, NuoE, NuoF, 
NuoI and NuoCD in E. coli) it is not a part of the operon encoding the bacterial enzyme. 
It has been suggested that permanent binding of Nqo15 to Complex I is needed for the 
stability of the enzyme in thermophiles (Sazanov and Hinchliffe, 2006). Since this subunit 
has homology to the frataxin protein family, it can also be involved in storage of iron, 
which is used for reconstitution of the neighboring iron-sulfur clusters N3 and N1a 
(Hinchliffe et al., 2006; Sazanov and Hinchliffe, 2006).   
  Sequence analysis of the ‘central’ subunits of Complex I has prompted the 
suggestion that this protein has evolved from the preexisting modules (Friedrich and 
Scheide, 2000; Friedrich and Weiss, 1997). This conclusion correlates with the 
experimental observation that upon treatment with a detergent the isolated bacterial 
Complex I can be cleaved into three big fragments (Leif et al., 1995).  Three hydrophilic 
subunits, NuoE, NuoF and NuoG, are similar to non-energy converting NAD+-reducing 
hydrogenases (Pilkington et al., 1991) and comprise the NADH-dehydrogenase fragment 
of the hydrophilic domain of Complex I (Leif et al., 1995) (Table 1). This three subunit 
fragment serves as an electron input of the protein (Braun et al., 1998).  It is also capable 
of catalyzing an artificial reaction of electron transfer from NADH to a number of 
water-soluble electron acceptors, such as FeCy and HAR (Vinogradov, 1998), which are 
bound at a specific site close to the flavin and accept electrons most probably from this 
redox cofactor (Dooijewaard and Slater, 1976; Gavrikova et al., 1995; Sled' and 
Vinogradov, 1993; Zickermann et al., 2000).  The reduction of artificial electron 
acceptors is insensitive to specific inhibitors of Complex I and not coupled to proton 
transfer. The connecting fragment of the hydrophilic domain consists of NuoCD, NuoB 
and NuoI subunits, and is located between the NADH-dehydrogenase and membrane 
fragments. These subunits have homologues in the family of membrane-bound 
dehydrogenases (Friedrich et al., 1993; Weidner et al., 1993). NuoB and NuoD have an 
intrinsic homology with small and big subunits of bacterial [NiFe] hydrogenases (Albracht, 
1993; Volbeda et al., 1995). Two fragments comprising the hydrophilic domain can be 
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easily distinguished on the resolved crystal structure (Fig. 2A) (Sazanov and Hinchliffe, 
2006). The third fragment in Complex I is the membrane domain which serves as a 
transporter module. It contains seven subunits three of which are homologues to 
cation/proton antiporters (Friedrich and Scheide, 2000) (see below). 
2.1.2. The hydrophobic domain 
 Present knowledge of the structure of the hydrophobic domain is limited, but this 
part of the enzyme must be involved in quinone binding and also be responsible for proton 
pumping. The membrane arm of E. coli Complex I is composed of seven hydrophobic 
subunits, small NuoA, NuoH, NuoJ, NuoK and large NuoL, NuoM and NuoN, which 
have been predicted to form approximately 60 ?-helices spanning the membrane 
(Bernardo et al., 2000; Kao et al., 2002; Kao et al., 2003; Mathiesen and Hagerhall, 2002; 
Roth and Hagerhall, 2001). The 3D-structure of the membrane domain is not yet known. 
Tentative assignment of subunit localization within the membrane domain has been done 
based on the following: the results of cross-linking experiments (Di Bernardo and Yagi, 
2001; Kao et  al., 2004b); mutagenesis (Bai and Attardi, 1998; Cardol et al., 2002; 
Sazanov et  al., 2000); fragmentation of Complex I with detergents (Holt et al., 2003; 
Sazanov et al., 2000); cryo-electron microscopy of two-dimensional crystals of the 
membrane part of Complex I (Baranova et al., 2007a; Sazanov and Walker, 2000); and 
single-particle analysis of the protein fragmentized by detergent (Baranova et al., 2007b) 
(Fig. 2A). It has been suggested that subunits NuoA, H, J and K form the proximal part 
of the membrane arm. In other words, they are located in the area of the junction between 
two domains where the quinone-binding site has been proposed to reside (Sazanov and 
Hinchliffe, 2006; Sazanov, 2007). The site-directed mutagenesis of the conserved 
intramembrane acidic amino acid residues in NuoA (Kao et al., 2004a), NuoJ (Kao et al., 
2005a), NuoH (Kurki et al., 2000) and NuoK (Kao et al., 2005b; Kervinen et al., 2004) 
has revealed that these subunits are involved in the process of quinone reduction. Two of 
the large subunits, NuoM and NuoL, are located in the distal part of the membrane 
domain and clearly separated from the others (Baranova et al., 2007a; Baranova et al., 
2007b). The remaining NuoN, even if it could be considered to be located in the middle 
of the membrane domain, tends to be adjacent more to the proximal than to the distal part 
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of the membrane domain (Baranova et al., 2007a).  Sequence analysis of the NuoM, N 
and L has revealed that they are similar to each other and related to the family of 
multisubunit K+ or Na+/H+ antiporters (Fearnley and Walker, 1992; Hiramatsu et al., 
1998; Kikuno and Miyata, 1985; Mathiesen and Hagerhall, 2002). It is very probable that 
these subunits are involved in proton translocation by Complex I. This suggestion is also 
favored by the results of site-directed mutagenesis of the NuoM and NuoN subunits 
(Amarneh and Vik, 2003; Torres-Bacete et al., 2007).  
 Native inhibitors of Complex I are being widely used for probing the structure 
and function of the membrane domain of the protein. They are hydrophobic or 
amphipathic naturally occurring compounds which occur naturally and interact within the 
hydrophobic part of the enzyme and compete with the native electron acceptor for the 
binding site. Inhibitors were divided into three groups according to their steady-state 
inhibition kinetics (Degli Esposti, 1998). The first group is comprised of antagonists of 
ubiquinone (type A). Members of the second group displace ubisemiquinone (type B) and 
members of the third (type C) are antagonists of the formed ubiquinol (Degli Esposti, 
1998). For example, piericidin A belongs to type A inhibitors; the classical inhibitor of 
mitochondrial Complex I, rotenone – to type B, and capsaicin A – to type C. However, 
it should be noted that in contrast to mitochondrial Complex I some of its bacterial 
analogs are not sensitive to rotenone (Friedrich et al., 1994). The most potent 
competitive inhibitors of quinone reductase activity are the members of the annonaceous 
acetogenin family (type A) (Degli Esposti et  al., 1994; Shimada et al., 1998), which 
inhibit mitochondrial and bacterial Complex I in the nanomolar concentration range 
(Degli Esposti et al., 1994) (Paper II). One of the commonly used representatives of this 
family is rolliniastatin (Hui et al., 1989). Studies of the direct competition between 
inhibitors of different types have revealed that they have overlapping binding sites 
(Friedrich et  al., 1994; Okun et al., 1999; Tormo and Estornell, 2000). It has been 
concluded that Complex I has a single pocket in the membrane domain which 
accommodates the quinone-binding site as well as binding sites for specific inhibitors with 
a different structure. Thus far there is no consensus on subunits comprising the quinone- 
and inhibitor-binding sites. Based on the resolved crystal structure of the hydrophilic 
domain of T. thermophilus Complex I it has been suggested that subunits Nqo4 and Nqo6 
(NuoB and NuoD in E. coli) from the connecting fragment accommodate the head group 
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of quinone (Sazanov and Hinchliffe, 2006), while subunits located in the proximal part of 
the membrane arm should accommodate its hydrophobic tail. This suggestion is in line 
with results of the mutagenesis work on R. capsulatus Complex I which revealed several 
mutations in the NuoD subunit that cause resistance towards potent inhibitors of the 
quinone-binding site, piericidin and rotenone, and decrease the rate of quinone reduction 
(Prieur et al., 2001; Dupuis et al., 2001). Photolabelling of Complex I showed that the 
NuoB (Schuler and Casida, 2001) and NuoH (Murai et al., 2007; Schuler and Casida, 
2001) subunits are indeed involved in the binding of quinone and inhibitors. Unexpectedly, 
NuoL (Nakamaru-Ogiso et al., 2003) and NuoM (Gong et al., 2003), located in the distal 
part of the hydrophobic domain were also labeled. These results imply the presence of at 
least two quinone-binding sites in Complex I. Since these findings are controversial, 
further experiments are clearly needed.   
2.2. Redox groups  
2.2.1. Flavin 
Flavin mononucleotide is the primary electron acceptor in Complex I. It simul-
taneously accepts two electrons and a proton in the form of a hydride from NADH 
(Ghisla and Massey, 1989) and  serves as a converter between strictly two-electron donor 
NADH and strictly one-electron carriers, iron-sulfur clusters (Sled' et al., 1994). Flavin is 
non–covalently bound (Rao et al., 1963) to the NuoF subunit (Table 1) (Pilkington et al., 
1991) which is located at the top of the hydrophilic domain (Fig. 2) (Sazanov and 
Hinchliffe, 2006). Using a photoactive arylazido derivative of NAD+ it was shown that the 
NADH-binding site also resides within the same subunit (Chen and Guillory, 1981; Chen 
and Guillory, 1984).  Indeed, the crystal structure of the hydrophilic domain of T. 
thermophilus Complex I showed that the FMN is located in a cavity which is large 
enough to accommodate one molecule of NADH (Sazanov and Hinchliffe, 2006).    
 Studies have also been made into the thermodynamic properties of the flavin in 
mitochondrial Complex I. The midpoint redox potentials of two one-electron transitions 
of the flavin, Em,7.51/0 and Em,7.52/1, were found to have values of  – 415 mV and – 336 mV, 
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respectively (Sled' et al., 1994). The midpoint potential of the two-electron reduction of 
the flavin, Em,7.02/0, was determined to be about – 340 mV (Barker et al., 2007;  Esterhazy 
et al., 2008; Sled' et al., 1994). We obtained a similar value for the flavin in E. coli 
Complex I (– 350 mV, pH 7.5) (Paper III). The midpoint potential of FMN in Complex 
I is approx. 130-140 mV lower than that of the free flavin in an aqueous solution (– 207 
mV, pH 7.0) (Draper and Ingraham, 1968). This downshift is probably needed for 
matching the midpoint potential of a donor, NADH, which has the Em value of – 335 mV, 
pH 7.5 (Zu et  al., 2003; Clark, 1960). A close inspection of the flavin-binding site 
revealed that the FMN is surrounded by four strictly conserved acidic amino acid residues, 
which could be responsible for maintaining its low redox potential (PDB entry 2FUG, 
chain 1). A similar case of downshifting of the redox potential of non-covalently bound 
flavin by acidic amino acid residues has been described for flavodoxin from Clostridium 
beijerinckii (Bradley and Swenson, 1999).           
2.2.2. Iron-sulfur clusters 
 Complex I derived from most sources contains eight iron-sulfur clusters 
(Fearnley and Walker, 1992; Weidner et al., 1993; Yagi et al., 1993), in accordance with 
the number of conserved sequence motifs. However, in some bacteria, such as E. coli and 
T. thermophilus, Complex I carries one additional iron-sulfur cluster (Yano et al., 1997; 
Friedrich, 1998).  The most reliable methodology for detecting iron-sulfur clusters and 
studying their properties is EPR spectroscopy at low temperatures (Palmer, 1985).  Using 
this method, individual spectra of five Fe-S centers have been resolved in bovine enzyme 
reduced with NADH (Ohnishi, 1998). They have been designated as N1, N2, N3, N4, and 
N5, according to their spin relaxation rates (the higher the cluster number, the lower the 
optimal temperature at which the spectrum of the cluster can be seen). Complex I has two 
binuclear clusters named N1a and N1b. In mitochondrial enzyme they have different 
redox properties (see below) and only N1b can be detected after reduction of the protein 
with NADH, whereas in bacterial enzyme signals derived from both clusters can be 
observed. Since binuclear clusters have slow spin relaxation rates, their spectra can be 
detected and studied separately from tetranuclear centers at higher temperatures (>30K). 
All other clusters in Complex I are tetranuclear, and can be seen at temperatures lower 
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than 20 K and high microwave power. In principle, all iron-sulfur clusters present in a 
protein should be EPR visible when they are reduced — present in the paramagnetic state 
— but for some unknown reasons, this is not the case for Complex I (Ohnishi, 1998). 
Moreover, the number of EPR detectable clusters varies with the source of the enzyme. 
Thus, five clusters were determined in Y. lipolytica (Djafarzadeh et al., 2000) and E. coli 
Complex I (Leif et al., 1995), and only four in the enzyme from N. crassa (Wang et al., 
1991). Identification of the subunit localization of individual Fe-S clusters  (Table 1) has 
been done on the basis of EPR analysis of a) the protein with disrupted subunits, b) 
subcomplexes of Complex I and c) its overexpressed and purified individual subunits (see 
below).   
It has been shown that the N1a cluster is located in the NuoE (Nqo2/24 kDa) 
subunit (Yano et al., 1994a; Yano et al., 1994b; Yano et al., 1995); N3 resides in the 
NuoF subunit (Nqo1/51kDa) where  the NADH- and FMN-binding sites are located 
(Fecke et al., 1994; Yano et al., 1996); and that the NuoG (Nqo3/75kDa) contains one 
binuclear center N1b (Yano et al., 1995), and two tetranuclear clusters, N4 (Yano et al., 
1995) and N5 (Yano et al., 2003).   
The NuoB (Nqo6/PSST) subunit has a unique sequence motif for binding of the 
tetranuclear cluster N2 (Ahlers et al., 2000; Duarte et al., 2002; Flemming et al., 2003). 
The EPR spectra of two tetranuclear clusters have been detected in the overexpressed 
and purified subunit NuoI from P. denitrificans (Ohnishi, 1998). These clusters have also 
been studied using UV/Vis spectroscopy, and have been designated as N6a and N6b 
(Rasmussen et al., 2001).  
All these studies were the basis for the assignment of Fe-S clusters in the resolved 
crystal structure of the hydrophilic domain of T. thermophilus Complex I (Sazanov and 
Hinchliffe, 2006). The 3D-structure also showed the position of additional cluster ligated 
by the NuoG subunit.  This center was named as N7. At the present time it is clear that 
seven clusters, N3, N1b, N4, N5, N6a, N6b and N2 compose a chain through which 
electrons are transferred from the flavin to the ubiquinone, while clusters N1a and N7 are 
placed outside of this chain (Fig. 2B) (Sazanov and Hinchliffe, 2006). Recently it has been 
shown that cluster N7 is not involved in electron transfer, but needed for stability of the 
enzyme (Pohl et  al., 2007). Considering redox properties of iron-sulfur clusters, it is 
widely  accepted  that  most  of  them,  N1b,  N3,  N4,  N5,  N6a  and  N6b,  have  a  
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pH-independent midpoint potential of about – 250mV (pH 7.0) (Ingledew and Ohnishi, 
1980; Ohnishi, 1998; Rasmussen et al., 2001). Therefore these centers are called 
isopotential. The midpoint potential of the binuclear cluster N1a in mitochondrial 
Complex I was found to have the very low value of  – 400 mV (Ohnishi, 1998;  Zu et al., 
2002) and also to be pH-dependent (– 60 mV/pH) (Ingledew and Ohnishi, 1980; 
Meinhardt et al., 1987; Zu et al., 2002). However, in bacterial enzyme this cluster has a 
higher value of Em, such as – 150 mV and – 250 mV in Complex I from P. denitrificans 
(Meinhardt et al., 1987) and E. coli (Leif et al., 1995), respectively. Clusters N1a and N3 
are the closest to the flavin. Considering the order in which the flavin donates electrons to 
them, it  was suggested that the first  electron is going to N3, because it  is  located at  a 
distance of 7.6 Å from the flavin (Sazanov and Hinchliffe, 2006) and has strong spin-spin 
interaction with semireduced flavin (Sled' et al., 1994).  The N1a cluster is more distal 
(Fig. 2B) and it accepts the second electron from the reduced flavin. It has been suggested 
that this cluster may play the role of an antioxidant in Complex I, preventing accumulation 
of the flavosemiquinone radical which can be the source of ROS production (Sazanov, 
2007).  
The last center in the chain is tetranuclear N2.  The midpoint potential of N2 is 
pH-dependent (– 60 mV/pH) (Ingledew and Ohnishi, 1980; Meinhardt et al., 1987) and 
has the highest value among all iron-sulfur clusters in Complex I. The Em value for N2 
was reported within the range from – 30 mV (Krishnamoorthy and Hinkle, 1988) to  
– 220 mV (Leif et al., 1995).  The EPR studies of bovine enzyme revealed a magnetic 
interaction of N2 with ubisemiquinone radicals bound to Complex I (see below) 
(Magnitsky et al., 2002; Ohnishi et al., 1998a; Vinogradov et al., 1995). A distance of 
12Å has been calculated between N2 and fast relaxing ubisemiquinone (Vinogradov et al., 
1995). On the basis of all these findings, cluster N2 is considered an immediate electron 
donor for ubiquinone.  
 
2.3. Semiquinones 
Thus far EPR signals of ubisemiquinone radicals associated with Complex I have 
been observed in isolated bovine enzyme (Suzuki and King, 1983) and in submitochon-
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drial particles derived from bovine heart (De Jong et al., 1994; De Jong and Albracht, 
1994; Kotlyar et al., 1990; Magnitsky et al., 2002; Salerno et al., 1979; van Belzen et al., 
1997; Vinogradov et al., 1995). Two distinct species of ubisemiquinone have been 
identified, named SQNfast and SQNslow, based on their spin relaxation rate (Vinogradov et 
al., 1995; Magnitsky et al., 2002). Extremely fast relaxing SQNfast can be detected only 
in tightly coupled membrane particles. It is sensitive to the electrochemical proton 
gradient across the membrane and specific inhibitors of Complex I (Magnitsky et al., 
2002; Vinogradov et al., 1995). A fast rate of relaxation of SQNfast indicates that this 
radical magnetically interacts with a neighboring paramagnetic center. Indeed, analysis of 
the effect of membrane energization on the saturation of SQNfast signal and properties of 
the spectra of N2 cluster revealed that they are correlated with each other (De Jong et al., 
1994). Splitting of the characteristic signal of N2 cluster was interpreted as a spin-spin 
interaction with SQNfast. Considering dipolar coupling between spins which leads to 
broadening and splitting of the signal, the distance between N2 and the fast relaxing 
semiquinone radical was calculated as 12 Å (Vinogradov et al., 1995; Yano et al., 2005).  
In contrast to the fast relaxing semiquinone radical, the SQNslow is not sensitive to 
??H+ and can be detected in uncoupled SMP. Another characteristic of the slow relaxing 
ubisemiquinone radical is its low sensivity to Complex I inhibitors (Magnitsky et al., 2002; 
Ohnishi et al., 2005; Yano et al., 2005). The SQNslow also magnetically interacts with the 
N2 cluster, but this interaction is weak. The distance between these two centers was 
estimated to be about 30 Å (Ohnishi, 1998; Vinogradov et al., 1995).  
2.4. ROS production by Complex I 
Since the redox cofactors of Complex I have the lowest midpoint potentials within 
the respiratory chain, it is widely considered that Complex I is one of the main sources of 
reactive oxygen species (ROS), such as superoxide anion and hydrogen peroxide, in 
mitochondria (Brand et al., 2004; Raha and Robinson, 2000; Turrens, 2003). Studies of 
the mechanism of ROS production by Complex I are of particular interest, because of the 
biological significance of ROS. Reactive oxygen species damage cell structures, DNA 
and RNA and are involved in the processes of oxidative stress and aging (Balaban et al., 
2005). There are two tentative sites for ROS production in Complex I: the flavin and the 
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ubiquinone, since both of them have been detected in the radical form (Sled' et al., 1994; 
Yano et al., 2005). There are several lines of evidence suggesting that most probably fully 
reduced or semireduced flavin is the source of reactive oxygen species in Complex I. It 
has been shown that the dependence of ROS production on the pre-set redox potential 
can be described as a Nernstian curve with a midpoint potential of  – 360 mV (pH 7.5), 
which corresponds to the potential of a two-electron transition of the flavin (Kussmaul 
and Hirst, 2006). The pH optimum for ubiquinone reduction differs from that for 
superoxide generation and the latter’s rate is not sensitive to the inhibitors of the 
quinone-binding site (Galkin and Brandt, 2005). Remarkably, it was found also that 
mitochondrial Complex I presumably generates O2•?, while its bacterial counterpart – 
H2O2 (Esterhazy et al., 2008).  
2.5. Proton translocation stoichiometry 
The first determinations of proton translocation stoichiometry of Complex I 
were done using the oxidant ‘pulse’ method introduced by Mitchell and Moyle (Mitchell 
and Moyle, 1967). In this technique, a defined quantity of oxygen is added into a 
suspension of anaerobic mitochondria. This initiates a brief respiratory burst accompanied 
by proton ejection from the mitochondrial matrix, which can be measured with a 
pH-sensitive electrode. Using selective conditions and modifications of the oxidant 
‘pulse’ method, it was reported that Complex I translocates one proton per electron 
(Lawford and Garland, 1972a; Lawford and Garland, 1972b; Mitchell and Moyle, 1967; 
Ragan and Hinkle, 1975). Therefore it was suggested that Complex I works as a Q-loop 
(Lawford and Garland, 1972b; Mitchell and Moyle, 1967). However, due to the technical 
limitations of the used oxidant pulse approach the determined H+/e¯ ratio was 
underestimated (Lawford and Garland, 1973; Brand et al., 1976). Later, Pozzan and 
co-workers based on their comparative studies of H+/e  ¯stoichiometries of Complex I and 
Complex III, suggested that the former pumps 2 protons per electron (Pozzan et al., 
1979). The first direct evidence that Complex I works as a proton pump was published 
by Wikström (Wikström, 1984b). The experiment was simple and elegant. The intact 
anaerobic mitochondria were incubated with either hydroxybutyrate or succinate. The 
alkalinization of the matrix after the pulse of ferricyanide as an oxidant was followed 
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spectrophotometrically using a pH sensitive membrane permeable probe, neutral red 
(Junge et al., 1979). Optical absorption of this probe changes proportionally in response 
to the change of proton concentration in the mitochondrial matrix (Wikström, 1984a). As 
a result, when hydroxybutyrate was used as a substrate, the linear dependence of the 
extent of alkalinization on the amount of added oxidant had a 2.8-times greater slope than 
in the case of succinate. The same result was obtained in a set of similar experiments 
where charge displacement was measured in response to oxidation by ferricyanide using 
potential sensitive dye safranine, which had been reported as a probe for measurements 
of mitochondrial membrane potential (Akerman and Wikström, 1976).  Since at that time 
it was already known that the q+/e¯ ratio for the span between succinate and cytochrome 
c (or ferricyanide) is one (Leung and Hinkle, 1975), the obtained results indicated that the 
H+/e  ¯and q+/e¯ ratio for the span between NADH and ubiquinone is 2. Thus it was shown 
that Complex I translocates 2 protons per electron (Wikström, 1984b). Later, the proton 
pumping stoichiometry of Complex I was measured using submitochondrial particles 
derived from bovine heart mitochondria (Galkin et al., 1999) and finally in proteolipo-
somes with a reconstituted enzyme isolated from Yarrowia lipolytica (Galkin et al., 
2006). These works further supported the conclusion that the H+/e¯ stoichiometry of 
mitochondrial Complex I has the value of 2. Unfortunately, for bacterial Complex I the 
proton pumping stoichiometry is not so well defined as it is for its mitochondrial analog. 
The main obstacle for measurement of H+/e  ¯ratio for NDH-I in the intact bacterial cells 
is the presence of other membrane-bound respiratory chain linked 
NADH-dehydrogenases (see Chapter 1.2), which do not pump protons. Their activity 
decreases the H+/e¯ ratio measured for Complex I.  So far, there is only one report on 
proton pumping stoichiometry in bacterial Complex I (Bogachev et al., 1996). For these 
measurements the authors used E. coli cells grown anaerobically in the presence of 
dimethyl sulfoxide (DMSO). Under these conditions the respiratory chain of this bacteria 
consists of NDH-I, terminal cytochrome bd oxidase and dimethyl sulfoxide reductase. On 
the basis of the extent of acidification in the media in response to a pulse of a defined 
amount of either O2 or DMSO, the H+/e  ¯ stoichiometry for Complex I and Complex I 
plus bd oxidase was determined as 1.5 and 2.5, respectively. Therefore, it was concluded 
that Complex I pumps at least 1.5 protons per electron (Bogachev et al., 1996). Low 
stoichiometry was explained by the fact that in anaerobic conditions menaquinone is used 
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in the E. coli respiratory chain as an electron acceptor. Since it has a more negative redox 
potential than ubiquinone, the energy released upon its reduction with NADH by 
Complex I may not be enough for the translocation of four protons across the membrane 
(Bongaerts et al., 1995). The obtained H+/e¯ stoichiometry does not exclude the 
possibility that in aerobically grown E. coli cells this ratio is higher, but this hypothesis has 
not been tested yet. 
2.6. Proposed mechanism of proton pumping 
At the present time two kinds of hypotheses explaining the molecular mechanism 
of Complex I are being discussed. The first one is referred to as direct (redox-driven) 
coupling (Dutton et al., 1998; Ohnishi and Salerno, 2005).  It is based on the observation 
of two distinct species of ubisemiquinone associated with Complex I (Vinogradov et al., 
1995; Yano et al., 2005) and therefore employs two types of quinone molecules, which 
reside in membrane dielectric. One of them is exchangeable with the membrane quinone 
pool, while another is tightly bound to the protein and serves as the gate and the coupling 
site. According to this model, tightly bound quinone accepts electrons from the N2 cluster 
with simultaneous acquisition of two protons from the matrix side of the membrane. The 
energy released upon this redox reaction is used to convert formed ubiquinol into a state 
in which it can release protons to the cytoplasmic side of the membrane with simultaneous 
transfer of electrons to the molecule of the exchangeable quinone. Then tightly bound 
quinone returns to the initial ‘input’ state in which it can be again reduced by N2 and the 
exchangeable quinone, after uptake of two protons from the matrix side in order to 
accomplish redox chemistry, thereby dissociating from the protein. Thus the proton 
pumping stoichiometry approaches the value of 4H+/2e? (Ohnishi and Salerno, 2005)  
Another proposed mechanism of Complex I is called indirect conformation-driven 
coupling (Brandt et al., 2003; Brandt et al., 2005; Zickermann et al., 2003; Yagi and 
Matsuno-Yagi, 2003). It hypothesizes that only one molecule of quinone is involved in 
the mechanism and it is exchangeable with the membrane quinone pool. The essence of 
this hypothesis is that the reduction of the quinone by the N2 cluster results in long-range 
conformational changes which lead to proton translocation by distantly located 
antiporter-like subunits NuoN, NuoM and NuoL. Several lines of evidence favour this 
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hypothesis. For example, comparison of two-dimensional crystals of E. coli Complex I 
obtained in the presence and absence of nucleotides revealed conformational rear-
rangements in the protein structure upon reduction with NADH (Mamedova et al., 2004; 
Morgan and Sazanov, 2008). Large reorganization in the structure upon reduction was 
also detected in FT-IR experiments on Complex I (Hellwig et al., 2000). It is also possible 
that a combination of direct and indirect mechanisms occurs in Complex I (Baranova et 
al., 2007b; Friedrich, 2001; Sazanov et al., 2000), but in any case neither of the proposed 
models provides a comprehensive explanation of the mechanism of proton translocation 
by the membrane part of this respiratory enzyme.    
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3. AIMS OF THE PRESENT STUDY 
The main focus of this thesis was an extensive study of the electron transfer reactions 
in Complex I upon its reduction with NADH and an assessment of the mechanistic 
principle of the proton pumping by this energy transducing enzyme.  
 
? Since the techniques used in this study require a big amount of pure and 
active enzyme, the first objective was to establish a conventional protocol for 
purification of Complex I from E. coli and optimize the conditions for observation 
of its enzymatic activity. 
 
? The second objective was to determine accurately the midpoint potentials 
of the redox centers of Complex I by means of spectroelectrochemical and EPR 
redox titrations. 
 
? The third objective was to resolve real time electron transfer kinetics 
through the chain of iron-sulfur clusters, thereby providing answers to some 
questions on the principles of the molecular mechanism of coupled proton 
translocation by Complex I.  
 
? The fourth objective was to validate the involvement of the membrane 
subunit NuoM in the proton pumping process and propose the mechanism for 
energy coupling between the spatially separated Q-binding site and proton 
pumping subunits. 
 
? The  fifth  objective  was  to  assess  the  role  of  invariant  Glu95  from  the  
NADH-binding site (electron input in Complex I) and three conserved amino acid 
residues, Arg274, His224 and His228, located in the vicinity of the N2 cluster, the 
immediate electron donor for ubiquinone. 
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4. METHODOLOGY 
4.1. Isolation of Complex I 
For isolation of wild type Complex I, the E. coli strain MWC215 (Calhoun and 
Gennis, 1993) was used. It has a knockout of NDH-II that yields a 2-fold increase of the 
Complex I content in cytoplasmic membranes.  
For the membrane preparation and further purification of Complex I, the bacte-
rial cells were grown aerobically in a 25 L fermentor in LB medium at 37 ºC for approx. 
4h until the late exponential growth phase. The detailed description of the membrane 
preparation can be found in Papers II and VI. 
Since Complex I is stable only in a narrow pH range and sensitive to detergent 
concentration, its purification should be done in mild conditions. The developed protocol 
for Complex I purification consists of two ion-exchange chromatographies on the weak 
anion exchanger DEAE-Trisacryl M (BioSepra) and centrifugation in a sucrose density 
gradient (for details see Papers II and VI).  However,  the  last  step  has  recently  been  
replaced by gel filtration on Superdex 200 prep grade (GE Healthcare). For a single gel 
filtration chromatography 1ml of protein solution (10mg/ml) after two previous steps of 
ion exchange chromatography on DEAE-Trisacryl was applied onto a self-packed 130 
ml bed volume of Superdex 200 in an XK16/70 column (GE Healthcare), equilibrated 
with 50 mM MES/NaOH, pH6.0, containing 150 mM NaCl, 10% sucrose, 2.5% glycerol 
and 0.025% DDM. The elution was performed at 0.5 ml/min flow rate in the equilibration 
buffer. 
For site-directed mutagenesis of Complex I, the parental strain GR70N con-
taining both NDH-I and NDH-II (Green et al., 1984) was used. The details of the genetic 
manipulations can be found in Papers II, V and VI. Complex I from the parent GR70N 
strain was used as a control for the characterization of obtained mutations. In order to 
estimate the content of Complex I in membranes of GR70N and mutated strains and avoid 
interference from NDH-II, an analog of NADH, namely dNADH, was used for the 
activity measurements, because it is specific only for Complex I (Matsushita et al., 1987). 
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4.2. Measurements of the enzymatic activity 
 The ability of Complex I to catalyze the electron transfer from NADH to an 
electron acceptor is considered as its enzymatic activity. It can be measured with both 
membrane-bound and solubilized enzymes. The assay is based on spectrophotometrical 
measurement of the rate of NADH oxidation by following the decrease of absorption at 
340 nm where the spectrum of reduced NADH has a maximum. Therefore the activity is 
usually expressed in ?mol of NADH oxidized by mg of the protein per minute. In vivo 
E. coli Complex I catalyzes reduction of ubiquinone-8. This activity is referred to as 
native. For in vitro measurements an analog of the natural electron acceptor, decylu-
biquinone, was usually used.  Its reduction also requires the entire enzyme and is sensitive 
to inhibitors of Complex I. However, the measurement of the native activity can not be 
used for quantitative determinations of Complex I, since it is always limited by the low 
solubility  of  the  acceptor  in  an  aqueous  solution  and  therefore  a  low  rate  of  quinone  
exchange in the catalytic site of Complex I. In the present study we partially overcame this 
obstacle by adding into the reaction a mixture of purified ubiquinol bo3 oxidase, which 
facilitates turnover of Complex I by fast oxidation of ubiquinol dissociating from the 
catalytic site.  
 In  vitro,  a  number  of  artificial  electron  acceptors,  such  as  FeCy  and  HAR  
(Vinogradov, 1998), can be utilized besides DQ. Their reduction by Complex I is much 
faster than that of quinones, because it employs only FMN and the NADH-binding site 
that are located within the NADH-dehydrogenase fragment. Therefore, the rate of such 
artificial reactions virtually does not change upon isolation of Complex I from the 
membranes, and can be used as a measure of the enzyme purity. In the present study HAR 
was routinely used as an artificial electron acceptor, because, in contrast to FeCy, its 
reduction has no effect on the optical changes at 340 nm and it does not compete with 
NADH for the nucleotide-binding site (Gavrikova et al., 1995; Sled' and Vinogradov, 
1993).  In the present study we also found that a low concentration of potassium ions 
facilitates artificial activity of Complex I. Measurements of artificial and native enzymatic 
activities are described in detail in Papers I and VI. 
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4.3. Monitoring of proton pumping 
 Proton pumping activity of Complex I coupled with NADH:ubiquinone 
oxidoreduction can be registered either in membrane vesicles obtained from bacterial cells 
or in liposomes with reconstituted purified enzyme. In the former case one can follow 
energy dependent acidification of the interior of membrane particles by Complex I by 
means of the pH-sensitive fluorescent probe, acridine orange (?ex= 493 nm, ?em=530 nm) 
and estimate the efficiency of the proton pump by comparing the initial rate of 
acidification with ubiquinone reductase activity of the enzyme. Besides Complex I, native 
E. coli membrane vesicles contain NDH-II and terminal bo3 oxidase. In order to observe 
exclusively proton pumping activity of Complex I, dNADH was used as an electron 
donor, which cannot be utilized by an alternative NDH-II (Matsushita et al., 1987). Also, 
KCN was added in order to inactivate the terminal oxidase. The measurements were 
performed with ionophore valinomycin and potassium ions present, in order to maximize 
the ?pH component of the proton motive force generated by Complex I and reduce 
formation of the transmembrane potential, which inhibits proton pumping. Details of the 
assay are discussed in Paper V.  
 In proteoliposomes the proton pumping activity of Complex I was monitored by 
registration of the ?? component of the proton motive force by means of an electric 
potential-sensitive dye, Oxonol VI. At physiological pH oxonols are present in an anionic 
water-soluble form (Smith et al., 1976) which is characterized by an absorption maximum 
at approx. 600 nm (Bashford and Thayer, 1977). Generation of electric potential across 
the membrane in a way that the inside is more positive than the outside, results in Oxonol 
VI neutralization with simultaneous shift of its absorption maximum to 625 nm (Bashford 
and Thayer, 1977). Upon neutralization, Oxonol VI becomes insoluble and starts to 
precipitate, which results in quenching of its absorbance at 625 nm. In comparison to 
other oxonols, Oxonol VI is a more sensitive probe because of its short response time and 
large amplitude of the red shift in response to the formed electric potential (Smith et al., 
1976). The reconstitution of the isolated enzyme into proteoliposomes was completed in 
two steps. During the first one the protein was equilibrated with the mixture of soybean 
asolectin solubilized by sodium cholate. The formation of closed lipid bilayer vesicles 
containing the reconstituted protein was achieved by sequential additions of SM-2 
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Bio-Beads (Bio-Rad Laboratories) which slowly absorb the detergent from the 
protein-lipid mixture (Jasaitis et  al., 1999; Rigaud et al., 1995). During this process 
Complex I is incorporated into liposomes randomly in both orientations. Estimation of the 
ratio between the two orientations was based on NADH:HAR oxidoreductase activity of 
Complex I in proteoliposomes measured with and without alamethicine. Molecules of this 
antibiotic form channels in biological membranes thereby providing an access for the 
water-soluble NADH to the liposome interior where it can be oxidized by Complex I with 
the hydrophilic domain oriented inwards. Description of Complex I reconstitution into 
liposomes and details of the assay can be found in Paper II. 
4.4. EPR spectroscopy 
Properties  of  iron-sulfur  clusters  in  Complex  I  were  studied  by  means  of  EPR 
spectroscopy. Each of the Fe-S centers in reduced state has an individual EPR spectrum 
characterized by the special parameters of the magnetic field gx,  gy and gz, and unique 
EPR property, namely relaxation time. EPR studies of Complex I are complicated since 
the spectra of iron-sulfur clusters overlap and have very close g-values. In order to 
investigate the properties of a particular cluster separately from the others one has to use 
selective temperature and microwave power conditions under which the signal from the 
center of interest will dominate in the overall spectrum of Complex I.  
 We used EPR spectroscopy for several purposes. First, we detected and 
characterized the signals of iron-sulfur clusters of Complex I reduced by an excess of 
NADH. This is the so-called steady-state condition of the reduced enzyme (Paper I and 
II). Second, we resolved the kinetics of electron transfer through the chain of iron-sulfur 
clusters. This was done by ultra-fast freezing of the sample in the time range from tens of 
microseconds to tens of milliseconds after mixing it with NADH. EPR spectra of frozen 
samples were analyzed to follow the redox changes of individual Fe-S clusters, which 
allowed us to monitor the movement of two electrons delivered by NADH in real time 
(Paper IV). Third, we determined the midpoint potentials of Fe-S clusters in the intact 
enzyme by means of electrochemical redox titration in the presence of mediators. In this 
study  we  used  methyl  viologen  (Em= ? 455 mV), benzyl viologen (Em= ?360 mV), 
hexaammineruthenium (Em= 50 mV) and pentaammineruthenium (Em= ?130 mV). This 
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choice was based on the fact that these mediators do not interact with each other and 
provide fast equilibration between an electrode poised to a certain potential and protein 
in solution. The details of the equilibrium redox titration of iron-sulfur clusters can be 
found in Paper III. 
4.5. Optical spectroscopy 
In order to determine the midpoint potential of the flavin, we monitored changes 
of its optical spectra during redox titration of purified intact Complex I. The potential 
within  the  range  from ?500 to  ? 40  mV was  applied  with  steps  of  ±  20  mV for  both  
oxidative and reductive titrations using a potentiostat. To accelerate equilibrium between 
the electrode and the solubilized protein a set of redox mediators was added as for 
titration in the EPR cell. Absorption of the oxidized flavin has a pronounced maximum at 
450 nm characterized by a high extinction coefficient (?450=12.8 mM-1*cm-1) (Massey and 
Palmer, 1962). Iron-sulfur clusters also absorb in this region, but their contribution to the 
spectra is small because of their low extinction coefficients (?450= 4.1 mM-1*cm-1) (Fu et 
al., 1994; Mayhew et al., 1969). Analysis of the redox changes at 450 nm reveals the 
potential area where the slope of the titration curve is maximal, which corresponds to 
oxidation/reduction of the flavin. The first derivative from this titration curve gives a set 
of small overlapped peaks, corresponding to the midpoint potentials of the iron-sulfur 
clusters, and one sharp peak characterizing the midpoint potential of the flavin. Details of 
the experiment and data treatment are described in Papers III and VI.   
4.6. Homology modeling of Complex I from E. coli 
In the present study we probed the role of several conserved amino acid residues 
in electron and proton transfer reactions catalysed by Complex I. In order to verify the 
position of selected residues and explain the effect of the site-directed mutagenesis we 
made a prediction of molecular structure for the subunits where the selected amino acids 
are located. We made the homology modeling of the NuoF and NuoE subunits from E. 
coli Complex I using as templates the sequences of homologues subunits (Nqo1, Nqo2) 
from T. thermophilis enzyme  with  resolved  structure  (PDB  entry  2FUG,  chains  1,  2)  
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(Sazanov and Hinchliffe, 2006). A detailed description of the homology modeling can be 
found in Paper VI. 
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5. RESULTS AND DISCUSSION 
5.1. Purification of Complex I 
 
The purification procedure for E. coli 
Complex I was developed on the basis of 
previously published protocols (Leif et al., 
1995;  David et al., 2002). Initially our protocol 
consisted of two chromatography steps on the 
weak anion-exchanger DEAE-Trisacril M 
(BioSepra) followed by centrifugation in a 
sucrose density gradient. Recently, the last step 
has been replaced by gel filtration on Superdex 
200 prep grade (GE Healthcare), which has the 
same resolution as sucrose gradient but takes 
less time and is more reproducible. In contrast 
to published protocols (for example, Sazanov 
et al., 2003; Flemming et al., 2003) we decreased the detergent concentration during all 
chromatography steps, which resulted in an increased yield and higher ubiquinone 
reductase activity of the purified enzyme. The SDS–PAGE of the standard preparation 
of Complex I containing all subunits is shown in Figure 3. The assignment of the subunits 
is based on previously published studies (David et al., 2002; Sazanov et al., 2003) and our 
results from his-tag labeling of several subunits in wild type Complex I (our unpublished 
data).  
5.2. Recovery of the native activity of purified Complex I 
For  a  long  time  the  main  obstacle  in  research  of  Complex  I  has  been  the  low  
ubiquinone reductase activity of the purified enzyme. The intactness of the enzyme can 
be estimated by the ratio between its artificial and natural activities (see 2.1.1 and 4.2). 
 
Figure 3. Coomassie Blue-stained 
10-20% SDS-PAGE gel of purified wild 
type Complex I  (lane 2, 30 ?g) Lane 1: 
molecular mass markers (kDa).  
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The turnover of purified bovine Complex I was found to be of 900 s-1 and 30 s-1 with FeCy 
and ubiquinone, respectively (Finel et al., 1994). So, the ratio artificial/natural activity 
was 30. Almost the same value of 30-40 was obtained for purified E. coli Complex  I  
(David et al., 2002). However, this ratio is 1.5-2.5 for the membrane-bound either 
mitochondrial or bacterial Complex I (Prieur et al., 2001; Sled' and Vinogradov, 1993). 
Recently it was concluded that the quinone-reductase activity of Complex I  decreases 
during purification due to delipidation of this membrane protein (Dröse et  al., 2002; 
Sazanov et  al., 2003). For example, the turnover of quinone reduction catalyzed by 
purified Y. lipolytica and E. coli Complex I reached the values of 120 s-1 (Dröse et al., 
2002) and 200 s-1 (Sazanov et al., 2003) after treatment with phospholipids. It is worth 
noting  that  lipids  used  for  the  recovery  of  the  native  activity  of  the  protein  were  
solubilized with detergent, which might also have an effect on the activity.  
 In Paper I we studied separately the effects of DDM and phospholipids on the 
quinone-reductase activity of isolated Complex I.  
5.2.1. Activation of purified Complex I by detergent and phospholipids 
 DDM itself strongly stimulated quinone reductase activity of the purified 
Complex I. The dependence of the activity on detergent concentration had a bell shape 
with a maximum at 0.005%. At this concentration the total increase of the activity was 
over 10-fold from the value without added DDM into the assay. The higher concentra-
tions of the detergent most probably caused the cleavage of the protein, which explains 
the descending part of the dependence curve. Incubation with the phospholipids resulted 
in an additional 2-fold increase of the quinone reductase activity, but in this case the 
optimal detergent concentration in the assay decreased to a lower value of  0.0025%.  As 
a result the native activity of the isolated Complex I can reach the value of 8 or 18 ?mol 
NADH mg-1*min-1 (corresponding to turnovers 130 and 300 s-1 when calculated per 
flavin) in the assay with the detergent or after the activation, respectively. Since HAR 
reductase activity remained the same regardless the activation, of the order of 80-90 ?mol 
of NADH oxidised by mg  of protein per min,  the ratios between the artificial  and the 
native activities were found to be 10 and 4 for DDM and lipid treated enzyme, 
respectively.  For the membrane-bound E. coli Complex I this value was determined as 
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1.5-2. The higher artificial/native activity ratio for purified activated enzyme could be 
explained by different properties of the natural substrate, Q8, and DQ, the artificial 
electron acceptor that was used for the activity measurements. 
 We explained the activation of the isolated Complex I by conformational 
rearrangements in the junction between the hydrophilic and hydrophobic domains. The 
binding of additional detergent and/or phospholipid molecules to the surface of the 
delipidated enzyme helps the protein to adopt its native state, which it has in the 
membrane. This might result in an increase of the accessibility of the quinone-binding site 
for the electron acceptor and/or improvement of the electron transfer from the N2 cluster 
to quinone. This premise is based on the analysis of EPR spectra (see below) and kinetic 
parameters of the activated enzyme. Neither different DDM concentrations nor the 
activation procedure changed the Km of Complex I for ubiquinone. The activation by 
phospholipids resulted in only a 2-fold increase of Vmax in comparison with DDM treated 
enzyme. To exclude the possibility that DDM or phospholipids altered the structure of the 
native DQ-binding site, we titrated the native activity of Complex I with rolliniastatin 
(Okun et al., 1999; Tormo and Estornell, 2000) and found that  affinity of this inhibitor 
did not change due to detergent and lipid binding. 
5.2.2. Changes in EPR signals of Fe-S clusters 
The paramagnetic properties of the Fe-S clusters are affected by immediate 
protein surroundings; therefore any structural rearrangements may modify the EPR 
signals of these cofactors. Since the activation of Complex I likely affects the junction 
between hydrophilic and hydrophobic domains, one might expect to see changes in the 
EPR signals from clusters residing in the connecting fragment. Indeed, the treatment of 
Complex I with lipids resulted in an increase in the amplitude of the signals from two 
fast-relaxing tetranuclear clusters. One of them can be simulated with parameters close to 
those reported for N2 in E. coli (Leif et al., 1995). The other is most likely cluster N6b, 
which also resides in the connection fragment close to the membrane plane. The increase 
in these EPR signals could be due to positive shift of the values of the redox potentials of 
these clusters and/or magnetic decoupling of their spins from each other, or from another 
EPR-silent paramagnetic species.  
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5.3. Electron transfer kinetics in Complex I 
The best way to reveal a molecular mechanism of the energy converting enzyme 
is to develop an ultra-fast kinetic teqnique allowing measurement single events 
comprising its catalytic cycle.   The catalytic reaction of Complex I is extremely fast 
(kcat~300s-1), so it can not be captured by conventional techniques.  
Paper IV describes the resolved dynamics of the electron transfer through the 
chain of iron-sulfur clusters in Complex I by following the changes in their EPR signals 
upon reduction of the enzyme with NADH. We trapped the reaction in the time range 
from tens of microseconds to tens of milliseconds by freezing the sample using a specially 
developed ultra-fast freeze-quenching setup (Fig. 5 in Paper IV). Further EPR analysis 
of obtained samples revealed a time dependent order of the appearance of the signals 
derived from individual clusters. First, we observed an appearance of the signals from 
clusters N1a and N2. Then the features from other clusters started to appear in the spectra 
in addition to an increase in the N2 and N1a signals. Since the EPR spectra of [4Fe-4S] 
iron-sulfur clusters overlap we chose for the analysis only those clusters, which have well 
defined prominent signals. We analyzed the rate of the reduction of N1a, N1b, N2 and 
N6b centers. Their spectra were simulated with parameters which are very close to those 
reported elsewhere (Friedrich, 1998; Rasmussen et  al., 2001; Uhlmann and Friedrich, 
2005; Yano et  al., 1999). The signal from N6b was simulated based on our own 
assignment described in Paper II and III.    
The EPR spectra were collected from the samples frozen in time from 90 ?s to 8 
ms after mixing the enzyme with NADH. The kinetic spectra of selected iron-sulfur 
clusters were fitted with simulated signals and their amplitudes were plotted against time 
(Fig. 4). The data analysis showed that the major fraction of clusters N1a and N2 
undergoes a very fast reduction with a time constant (?) of ~90 ?s, implying that these 
clusters have the highest redox potentials. This conclusion is in line with previously 
determined Em for these centers (see Chapter 2.2.2) (Brandt, 2006; Friedrich, 1998; Leif 
et al., 1995; Ohnishi et al., 1998b; Uhlmann and Friedrich, 2005). A different behavior 
was observed for N1b and N6b clusters. The major fraction of these clusters was reduced 
slowly with the time constant of ? ~1.2 ms. 
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According to the 
electron tunneling 
theory (Moser et al., 
2006) and determined 
distances between FeS 
centers in Complex I 
(Sazanov and 
Hinchliffe, 2006) the 
electron transfer from 
FMN to N2 through 
the entire chain of 
iron-sulfur clusters is 
expected to proceed 
with a time constant of 
~100 ?s.  Since  the  observed  rate  is  close  to  the  theoretical  one,  it  is  obvious  that  the  
electron transfer in Complex I is unlikely to be coupled with other reactions such as 
proton transfer or conformational changes, otherwise the latter ones would slow down 
the process and result in a larger time constant. Since the rate of N1b and N6b reduction 
?? ~1.2 ms) is several orders of magnitude lower than the rate of electron transfer between 
clusters, we concluded that the reduction of these clusters is limited by a single process 
– dissociation of the product NAD+ from the nucleotide-binding site, where it prevents 
entry for the next NADH molecule, needed for further reduction of the enzyme.  
Using the method of an organic extraction of quinones we found that in our 
preparation each molecule of Complex I contains one tightly bound quinone. However, 
we did not observe formation of ubisemiquinone, which might imply a high thermody-
namic barrier for ubiquinone reduction to semiquinone radical. Possible implications of 
these findings for the proton translocation mechanism are discussed in Chapter 5.6.  
 
Figure 4. Kinetics of the redox changes of clusters N1a, N1b, N2 
and N6b after mixing of Complex I with NADH. The spin 
concentration of the individual FeS clusters was plotted against  
time and fitted with an exponential curve. Reproduced from Paper 
IV. 
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5.4. Determination of the midpoint potentials of the redox centers in 
Complex I 
 The characterization of the redox properties of the electron carriers in Complex 
I can provide a thermodynamic basis for an understanding of the mechanism of energy 
transduction by this enzyme. Nowadays, it is widely believed that all of them are 
isopotential with the Em value of about – 250 mV (Hirst, 2005; Ingledew and Ohnishi, 
1980; Ohnishi, 1998), except for N2 and N1a. The former has the highest redox potential 
among all clusters while the latter - the lowest, although the values of their potentials vary 
with the source of the enzyme (see Chapter 2.2.2). Moreover, not all iron-sulfur clusters 
in Complex I have a visible EPR signal after reduction with NADH (Ingledew et al., 1980; 
Ohnishi, 1998). Thus far the reason for this phenomenon is unclear.  
The recently resolved crystal structure of the hydrophilic domain of T. thermo-
philus Complex I (Sazanov and Hinchliffe, 2006) showed that the distances between 
iron-sulfur clusters in Complex I are in the range of 10.7–16.9 Å (Fig. 2B).  Considering 
that the dielectric constant inside the protein has a typical value of ?20 (Laurents et al., 
2003; Schutz and Warshel, 2001), one might predict an electrostatically induced negative 
cooperativity between iron-sulfur clusters upon reduction. This physical phenomenon can 
affect the redox properties of the clusters, for example, by decreasing the value of their 
midpoint potentials.  
 To date, the values of the midpoint potentials of the redox cofactors in Complex 
I were determined using submitochondrial particles (Ingledew and Ohnishi, 1980; 
Zwicker et al., 2006), bacterial membranes (Leif et  al., 1995; Meinhardt et al., 1987; 
Yano et al., 2003), fragments of Complex I (Barker et al., 2007) or overexpressed 
individual subunits (Yano et al., 2003; Zu et al., 2002). There is only one work where the 
intact isolated mitochondrial Complex I was used for redox titration of binuclear clusters 
(Ohnishi et al., 1981). Any electrochemical or potentiometric titration of Complex I is a 
complicated task. Firstly, it should be done in strictly anaerobic conditions. Secondly, 
selected mediators should facilitate equilibrium between the protein and an electrode 
poised to a certain potential, but should not interact with each other or with the protein. 
Thirdly, there are only two methods, optical and EPR spectroscopy, by which one can 
follow the redox changes of the flavin and iron-sulfur clusters.  In order to fulfil the listed 
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demands we used a special EPR and optical cells for continuous electrochemical redox 
titration of the redox active proteins. In this study, we for the first time presented 
titrations of purified intact bacterial Complex I. In order to keep the protein in a state 
close to that which it has in the membrane, we performed redox titration in the presence 
of lipids.  In our potentiometric redox titrations we applied potential in a broad range 
from – 500 to – 140 mV (Paper III). Using optical redox titration we determined the 
midpoint potential of the flavin. It has a value of – 350 mV (pH 7.5), that is in agreement 
with the value reported for the mitochondrial enzyme (Sled' et al., 1994). Redox 
properties of iron-sulfur clusters were studied using EPR spectroscopy. Using selective 
temperature and microwave power conditions we distinguished the signals of two 
binuclear clusters, N1a and N1b, from all the tetranuclear centers. Each binuclear Fe-S 
cluster has a well characterized spectrum that was used in its entity for the determination 
of the dependence of the spin concentration on the redox potential. In contrast, spectra 
of tetranuclear clusters are more complicated for decomposition, therefore the most 
prominent characteristic features, peaks and troughs, that belong to known [4Fe-4S] 
centers were used to obtain the titration curves (Fig. 4 in Paper III).  
The analysis of the EPR redox titration showed that the majority of clusters have 
complicated titration curves that could not be fitted with a simple one-electron Nernstian 
curve but only with the sum of at least two of them (see for example Fig. 5 in Paper III) 
(Table 2). These clusters are N1b, N3(7), N6b, N2 and one tetranuclear cluster, 
temporarily designated Nx, which had not been detected previously. Only the binuclear 
cluster N1a had a titration curve with a very clear one-electron transition. Its midpoint 
potential was determined to have a value of about – 235 mV, which was close to that 
published for E. coli enzyme by Leif and co-workers (Leif et al., 1995). However, in the 
mitochondrial counterpart of Complex I binuclear cluster N1a has a much lower midpoint 
potential of about – 400 mV (Ohnishi, 1998; Zu et al., 2002). Due to such a low Em value 
center N1a could not be EPR detected in the eukaryotic Complex I reduced with NADH. 
The reason for such a difference in redox properties between corresponding clusters from 
bacterial and mitochondrial enzyme is not yet clear. 
The titration of a very low potential Nx cluster was fitted with a one-electron 
Nernstian curve with an Em~ – 365 mV. Since the spin concentration of this cluster was 
estimated as one half in comparison to the other well characterized and determined 
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tetranuclear centers, we concluded that cluster Nx could have another redox transition, 
possibly at even lower potentials, which could not be achieved in our study. At slightly 
higher potential ranges we observed a signal of small amplitude from another, yet 
unidentified, tetranuclear cluster. This cluster is a very fast-relaxing one, since it could be 
seen at a temperature lower than 10 K and high microwave power. The titration of the 
prominent band in its spectra had a single transition with an Em~ – 330 mV. This signal 
has not yet been attributed to a particular iron-sulfur center in Complex I. A summary of 
our findings is presented in Table 2. 
 
Table 2 
Electrochemical and EPR spectral properties of the redox groups of Complex I from E. coli. 
Reproduced from Paper III. 
  
redox center Em (mV) 
The basis of titration 
profiles 
gxyz 
temperature 
(K) 
microwave 
power 
(mW) 
FMN 
–350 
(n=2)a 
    
   2Fe-2Sb   
N1a –235 simulated spectrum 1.920, 1.950, 2.00 
N1b –320, –245 simulated spectrum 
1.930, 1.938, 
2.021 
45 2 
   4Fe-4Sb   
N2 –300, –200 1.895, 2.045 
1.985, 1.904, 
2.045 
10 
N6b –315, –235 1.877, 2.089 
1.887, 1.894, 
2.089 
2, 10 
N3 or N7 –315 1.956 minus 1.947 1.90, 1.947, 2.046 
10 
2, 10 
Nx –365 1.932, 2.022 
1.931, 1.935, 
2.022 
 10 
N4 or N5 –330 1.929 1.929 5.5 10 
a Optical titration. b EPR titration 
 
We explained the complicated titration curves of the iron-sulfur clusters in terms 
of intrinsic electrostatic interactions between them in the entire Complex I during 
reduction of the protein under equilibrium conditions. This phenomenon has important 
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implications. First, negative repulsion between neighboring clusters results in a shift of 
their midpoint potentials to more negative values. The value of the shift(s) for a particular 
cluster is determined by: 1) the number of neighboring clusters, 2) their midpoint redox 
potentials, 3) distances between them and 4) dielectric constant in the protein. These 
factors together determine the energy of interaction between clusters. In order to 
illustrate the effect of electrostatic repulsion between neighbouring redox groups on the 
value of their midpoint potentials we developed a model that considers interaction 
between clusters N3, N1b, N4 and N5 located in the middle of the internal electron 
transport chain of Complex I during the reduction of the protein under equilibrium 
conditions (Paper III).  Second, the fact that some iron-sulfur clusters in Complex I are 
EPR-invisible could be explained by the negative repulsion from neigbouring redox active 
centers that strongly decreases their Em values. In other words, some clusters cannot be 
reduced by conventional reductants in order to become EPR detectable. 
 
5.5. The role of the conserved amino acid residues in the NADH- and 
quinone-binding sites 
In the present work we were interested in examining the conserved amino acid 
residues of Complex I that are involved in the reactions of electron and proton transfer. 
In this respect we studied the role of invariant glutamate 95 from the NADH-binding site 
(Paper VI) and conserved arginine 274, histidines 224 and 228 located in the vicinity of 
the quinone-binding site of Complex I (Paper II).   
5.5.1. The role of Glu95 in the process of substrate binding 
 The flavin-binding cavity in the Nqo1 subunit (NuoF in E. coli) has a very 
prominent feature – the presence of two invariant amino acid residues, glutamate 97 and 
tyrosine 180 that are exposed to the solvent and located in the vicinity of the FMN. It was 
suggested that they might be involved in the binding of NADH through interaction with 
its nicotinamide moiety (Sazanov and Hinchliffe, 2006). For Tyr180 this suggestion is in 
line with the results of the analysis of the double mutation Y204C/C206G in human 
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Complex I (Y204 is the counterpart of Y180 in T. thermophilus) which causes severe 
symptoms (Benit et al., 2001) that could be explained by interaction of these residues 
with FMN or/and NADH, but no such proof was available for Glu97. In order to assess 
its function we mutated the correspondent glutamate 95 in the NuoF subunit of E. coli 
Complex I for glutamine.   
If anionic Glu95 does indeed participate in the interaction with the nicotinamide 
moiety of the nucleotide, then the removal of its negative charge from the NADH-binding 
site would decrease affinity to the reaction 
product, NAD+, since the latter carries a positive 
charge on its pyridine ring. However, the 
opposite effect was observed. The affinity for 
NAD+ was increased 2.4-fold in the mutated 
enzyme in comparison to the wild type. The 
mutation also caused a 2-fold increase in KmNADH. 
In order to explain the effects of this mutation one 
should  take  into  account  that  at  neutral  pH  the  
overall charge of NAD+ is negative because of the 
two negative phosphate groups. We therefore 
suggested that the main role of Glu95 is not in the 
binding of nucleotide, but rather in the 
electrostatic repulsion of its negatively charged phosphates. This process facilitates 
release of the product NAD+ and, as a result, accelerates turnover of Complex I. This is 
in line with the finding that the affinity of the mutated Complex I for ADP-ribose, which 
differs from NAD+ by  the  absence  of  the  positively  charged  nicotinamide  moiety,  was  
increased 7.5-times in comparison to the wild type enzyme (Paper VI).   
Glutamate 95 is one of four conserved negatively charged amino acid residues 
surrounding the flavin at a distance of 4-6 Å from its isoalloxazine ring (Fig. 5), each of 
which contributes to the overall 130 mV negative shift in the redox potential of the 
protein-bound flavin in comparison to the free FMN (Em = – 220 mV, pH 7.5) in solution 
(see also Chapter 2.2.1). Optical redox titration of the purified E95Q mutant showed that 
the midpoint potential of the flavin shifted to positive values by 40 mV and resulted in a 
value of – 310 mV (versus –350 mV in the wild type as determined in Paper III). 
 
Figure 5. Conserved negatively 
charged amino acid residues 
surrounding the FMN in the modeled 
NuoF subunit of E. coli Complex  I.  
Atomic distances are represented in Å. 
 Structures are drawn using the VMD 
program (Humphrey et al., 1996). 
Reproduced from Paper VI. 
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Therefore, we postulated that another role of the negatively charged glutamate is to 
decrease the midpoint redox potential of the primary electron acceptor in Complex I.  
5.5.2. The role of conserved Arg274 and His224, His228 from the NuoCD subunit 
in the final step of electron transfer  
According to the hypothesis of the conformational driven coupling (Zickermann 
et al., 2003) (see Chapter 2.5) the amino acid residues surrounding the N2 cluster have 
a critical role in energy transduction. The role of several conserved amino acid residues 
located in the vicinity of N2 and the proposed quinone-binding site was probed by 
site-directed mutagenesis of the 49kDa subunit of Complex I from Yarrowia lipolytica 
(Brandt et al., 2005; Tocilescu et  al., 2007). Two conserved histidines, H91 and H95 
were found to be essential for the ubiquinone reductase activity, but their replacement did 
not affect the EPR spectra of N2, an immediate electron donor for ubiquinone (Grgic et 
al., 2004). These histidine residues are located at the edge of the “funnel” formed by the 
49 kDa subunit (the Nqo4 in T. thermophilus, the NuoCD in E. coli) and the PSST 
subunit (the Nqo6 in T. thermophilus, the NuoB in E. coli), where it was postulated that 
binding of the quinone head group occurred (Sazanov and Hinchliffe, 2006). Another 
highly conserved residue in the 49 kDa subunit (the NuoCD in E. coli), R141, was 
thought to reside close to N2 based on the analysis of the conserved structural fold of the 
[NiFe] dehydrogenase from which most probably the quinone-reducing part of the 
connecting fragment of Complex I had been evolved (Kashani-Poor et al., 2001).  The 
recently resolved structure of the hydrophilic domain of T. thermophilus Complex  I  
(Sazanov and Hinchliffe, 2006) showed that the distance between cluster N2 and R141 
(R84 in T. thermophilus) is only 5 Å. The replacement of R141 with alanine, methionine 
and lysine was reported to cause the loss of the N2 signal in the EPR spectra of Complex 
I reduced with NADH and dithionite, although the quinone reductase activity in the 
mutants remained significant (Grgic et al., 2004). On the basis of these results it was 
suggested that the N2 cluster was lost due to the mutation and cluster that should reside 
at a distance of ca. 5 Å from N2 became the immediate electron donor for the quinone. 
The best candidate for such a role could be cluster N6b. However, crystallographic data 
shows that the distance between N2 and N6b is 10.5 Å (PDB entry 2FUG), which means 
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that N6b is removed from quinone at approx. 22.5 Å and therefore could not be an 
efficient immediate electron donor for it. 
Since the particular features of Complex I might be organism specific, we made 
the mutations of corresponding amino acid residues, R274, H224, H228 from the NuoCD 
subunit of E. coli Complex  I  in  order  to  reveal  their  relevance  for  the  function  of  the  
enzyme. 
The H224A and H228A (H91 and H95 in Y. lipolytica) mutations did not affect 
the expression level of the enzyme, but caused decrease of the ubiquinone reductase 
activity by 50 % in comparison with the wild type. The reduction of ubiquinone by these 
mutants was specific, since their affinity to rolliniastatin did not change. Comparison of 
EPR spectra of wild type enzyme and these mutants showed no difference in the signals 
of binuclear and tetranuclear iron-sulfur clusters. These results showed that H224 and 
H228 are important for ubiquinone reduction but their presence is not an obligatory 
requirement. Mutation of arginine 274 for alanine caused more dramatic effects than 
mutations of histidines. Quinone reductase activity catalyzed by the R274A mutant 
dropped significantly, although the affinity of this enzyme to rolliniastatin, IC50, was 
approximately the same as in wild type, in the range of 1.4-2.4 nM. Analysis of the EPR 
spectra of the isolated mutated enzyme reduced with NADH showed the loss of a signal 
at g-values corresponding to the N2 spectrum, which was in agreement with the 
previously reported data on a corresponding mutation in Y.  lipolytica (Grgic et al., 2004) 
Complex I.  Further reduction of the mutant with dithionite at alkaline pH (Em = – 500 
mV) in the presence of methyl viologen caused the appearance of a signal similar to that 
of N2 (with the parameters gxyz = 1.900, 1.901, 2.045) but slightly broader and with 
smaller amplitude. Unexpectedly, the reduction with dithionite also caused an increase in 
the signal from another fast-relaxing tetranuclear iron-sulfur cluster.  This signal with 
parameters gxyz = 1.889, 1.905, 2.087 we assigned to N6b. Since the distance between the 
counterpart of R274 in T. thermophilus and  N6b  is  8  Å  (PDB  entry  2FUG)  and  the  
removal of the positive charge could affect the cluster located at a distance less than 10 
Å, cluster N6b was suggested to be the best candidate for such an assignment. In addition, 
it is also possible that in the entire enzyme the distance between arginine 274 from the 
NuoCD subunit and cluster N6b from NuoI could be even shorter than 8 Å, as determined 
based on crystal structure of the hydrophilic domain of T. thermophilus Complex  I,  
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because the connecting fragment with part of the postulated quinone-binding site could 
be distorted upon fragmentation of the enzyme.  
We explained the re-appearance of the signal from N2 in the mutant after the 
reduction with dithionite by a downshift of its redox potential caused by the removal of 
the neighbouring positive charge.  Hence arginine274 is one of the amino acids in the 
vicinity of N2 which maintain the high redox potential of this cluster.  
 We  also  tested  the  effect  of  the  mutations  on  the  proton-pumping  activity  of  
Complex I reconstituted into liposomes by monitoring ?? generation driven by 
NADH:quinone oxidoreduction. Electric potential was generated by all mutated enzymes, 
suggesting that none of the three amino acid residues, R274, H224, or H228, are involved 
in proton pumping directly.  
5.6. Proposed mechanism of proton pumping by Complex I 
Presently, three of the distantly located membrane subunits, NuoM, NuoN and 
NuoL, are considered to be involved directly in proton translocation across the 
membrane. This assumption is based on the relation of these subunits to a family of 
proton/cation antiporters (Hiramatsu et al., 1998; Mathiesen and Hagerhall, 2002). 
However, there is no hypothesis which satisfactory explains how the free energy released 
during quinone reduction is transferred at distance of 60-100 Å from the quinone-binding 
site to the distal part of the membrane domain.  
We found that conserved amino acid residues from the NuoN and NuoM subunits 
and their homologues in H+/K(Na)+ antiporters share a common pattern (Fig. 1 in Paper 
V). Prediction of its membrane topology revealed one very prominent feature – the 
presence of two lysines located within the membrane dielectric (Fig. 6). Such localization 
of charged amino acid residues is rare in membrane proteins. Site-directed mutagenesis 
of the conserved lysines, K217 and K247, from the NuoN subunit showed that they are 
essential for the enzyme activity (Amarneh and Vik, 2003). 
 In order to verify the role of corresponding lysines from the NuoM subunit, K234 
and K265, we used site-directed mutagenesis (Paper  V).  We found that  lysine  234  is  
essential for quinone reductase activity. Furthermore, we found that not only the charge 
is important, but also the properties of the side chain of the amino acid, since the 
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replacement of K234 by arginine resulted in an inactive enzyme as in the case of K234A 
mutation.  
 
Figure 6. Predicted membrane topology of the highly conserved residues comprising the common 
pattern found in the NuoN and NuoM subunits. Black crosses indicate residues, which are found to be 
essential for quinone reductase activity; grey crosses indicate residues, the replacement of which to 
alanine yielded only partial loss of quinone reductase activity. Results of site-directed mutagenesis of 
the NuoN subunit are published in (Amarneh and Vik, 2003). Reproduced from Paper V. 
 
The same results were obtained by Torres-Bacete and co-workers (Torres-Bacete 
et al., 2007). In contrast, the replacement of the corresponding lysine from the NuoN 
subunit, K217, by arginine resulted only in partial inactivation. The results of the 
replacement of the second conserved lysine from the NuoM subunit, K265, by alanine 
showed that it is not crucial for proton pumping and the activity of the enzyme, whereas 
the positive charge of the counterpart of this lysine in the NuoN subunit, K247, was found 
to be critical for enzyme activity. Substitution of this lysine for cysteine resulted in 
complete loss of the activity while K247R mutation had a minor effect. Thus one can 
conclude that in both NuoN and NuoM there is at least one conserved lysine essential for 
the activity and proton pumping by Complex I. Furthermore, these lysines are likely to be 
charge-uncompensated since neither NuoM nor NuoN appears to contain conserved 
acidic amino acid residues adjacent to them. Glutamate 133 from the NuoN subunit is 
unlikely to interact with one of the intramembrane lysines in this subunit since it is not 
critical for enzyme activity (Amarneh and Vik, 2003). We probed the role of the 
corresponding glutamate, E144, from the NuoM subunit by site-directed mutagenesis. 
Substitution of this glutamate for aspartate, E144D, had no effect on Complex I activity 
while substitution by hydrophobic uncharged alanine, E144A, resulted in complete loss 
of quinone reductase activity. However, according to the membrane topology predicted 
for the above-mentioned common pattern shared by three membrane subunits glutamate 
144 from NuoM is unlikely to be adjacent to lysine 234 and is therefore hardly a suitable 
partner for electrostatic interactions with the latter.  
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However,  one  cannot  exclude  another  possibility  that  lysines  from  NuoN  and  
NuoM might interact with the conserved acidic amino acid residues from another 
membrane subunit(s). It was found that uncompensated intramembrane Glu81 and Asp79 
from NuoA (Kao et  al.,  2004a)  and  two  glutamates  from  NuoK  are  essential  for  the  
activity of Complex I (Kao et al., 2005b; Kervinen et al.,  2004).  At  least  two  of  the  
mentioned acidic residues could be good candidates for an ion interaction with conserved 
lysines from the NuoN subunit. In contrast, for the NuoM subunit such a possibility is 
deemed to be unlikely, since it was suggested that it is located in the distal part of the 
membrane domain (Sazanov, 2000; Baranova et al., 2007b) and appears not to have 
extensive contacts with other subunits, except for NuoL (Baranova et al., 2007a).  
We  also  found  that  other  membrane  subunits,  NuoL  and  NuoH,  are  likely  to  
contain conserved lysines in their transmembrane helices. Thus one can assume that the 
hydrophobic domain contains at least four conserved intramembrane lysines arranged in 
a row and aligned parallel to the membrane surface.  The first lysine in this “chain” is 
located in the NuoH, the second in the NuoN, the third in the NuoM and the last one in 
the NuoL subunit. This assumption allowed us to propose a tentative principle governing 
redox-coupled proton pumping by Complex I (Paper  V). Recently, Baranova and 
co-workers (Baranova et al., 2007b) suggested that each of three membrane subunits, 
NuoN, NuoM and NuoL, could pump one proton, driven by long-range conformational 
changes. In contrast, we proposed that proton translocation by each of these subunits 
takes place through protonation and deprotonation of the key intramembrane lysine, 
which additionally can switch the orientation of its side chain towards the inside and 
outside of the membrane for proton uptake/release.  An example of such an alterna-
tive-access mechanism has been previously described for the functionally important 
protonatable glutamate in membrane H+/lactose symporter (Mirza et al., 2006) and 
aspartates in Na+/H+ antiporter NhaA (Hunte et  al., 2005). Regarding the principle of 
proton pumping by Complex I an important question can be raised about the state of the 
key intramembrane lysines since they appear to be electrostatically uncompensated. The 
predicted position of these residues in the low dielectric core of the membrane is indeed 
energetically unfavorable. Close inspection of the sequence details and predicted 
membrane topology of NuoH, NuoN, NuoM and NuoL showed the presence of several 
unconserved acidic amino acid residues in each of the subunits, some of which may even 
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be located in the same transmembrane helices where the key lysines reside, but the 
distances are not favorable for the formation of salt bridges. On the other hand, 
charge-uncompensated lysine could be placed in the middle of the membrane dielectric in 
a non-polar environment in case it is deprotonated. If, however, the intramembrane lysine 
is protonated it could be located at the bottom of a narrow “funnel” or “channel” 
providing  protonic access to the cytoplasmic/periplasmic side of the membrane. It is also 
possible that both of these suggested states of the key lysines occur during the operation 
of Complex I, and are altered by binding/reduction of the quinone in the active site. As an 
example, binding of the substrate might lead to subtle conformational changes in the first 
proton translocating subunit (NuoH), in its small part above the key lysine, which is 
located in a non-polar environment and therefore deprotonated. These rearrangements 
could result in the formation/opening of a temporary narrow “funnel” providing  access 
for water molecules from the cytoplasmic side of the membrane to this lysine, in which 
way it may become protonated. The latter event might result in charge imbalance and 
cause two processes. First, in order to release a proton later to the periplasmic side, the 
first proton translocating subunit might undergo small structural rearrangements resulting 
in re-orientation of the side chain of the protonated lysine towards the periplasmic side, 
thereby closing the temporary cytoplasmic “funnel” and opening of another one directed 
towards the periplasm. An example of such small rearrangements resulting in open-
ing/closing of the channels and change in the orientation of side chains of the key 
glutamates towards the periplasm or cytoplasm has been described for Na+/H+ antiporter 
NhaA (Hunte et al., 2005). Second, the charge imbalance on the first lysine and structural 
rearrangements in its vicinity might cause deprotonation of the second lysine in the row 
(located in the NuoN subunit), which is assumed to be protonated and to have access to 
the periplasmic side of the membrane (see below). Deprotonation of this lysine could be 
accompanied by closing of the temporary “funnel” connecting this lysine with the 
periplasm in a way that the second lysine is left in a non-polar environment in a 
deprotonated state. Release of the proton by the second lysine and charge imbalance 
caused by this process in turn could stimulate small conformation rearrangements above 
the third deprotonated lysine (located in the NuoM subunit) resulting in forma-
tion/opening of another temporary “funnel” through which a proton can be acquired from 
the cytoplasmic side of the membrane in a way described for the first key lysine. Then the 
  58 
process can propagate further along the membrane domain of the enzyme. It is also worth 
noting that the structural rearrangements in the proton pumping subunits prompted by 
quinone binding and reduction should be small in order to maintain a high turnover of 
Complex I. The described explanation of how the protein can tolerate charge-uncom-
pensated lysines in the membrane dielectric is rather speculative and assumes that two of 
the four key lysines in the membrane domain of Complex I should be deprotonated and 
two – protonated in an “as prepared” enzyme. The resolved crystal structure of the entire 
enzyme can verify whether that is the case or not. However, there are two observations 
that might be considered to be in line with the proposed principle. First, FT-IR studies on 
E. coli Complex I suggested that the redox transitions of the flavin and iron-sulfur 
clusters induce conformational change of the protein (Hellwig et al., 2000). Second, the 
electron microscopy images of the frozen-hydrated crystals of the hydrophobic domain 
of E. coli Complex I (Baranova et al., 2007a) revealed low density areas in the 8 Å 
resolution projection map that could correspond to the narrow cytoplasmicaly oriented 
“funnels” above the key lysines.   
Ubiquinone binding and reduction likely take place in the proximal part of the 
membrane domain, formed by the small NuoA, NuoJ, NuoK and NuoH subunits, adjacent 
to the bottom part of the hydrophilic domain where N2 resides. Thus, the cluster of these 
subunits could be considered a “coupling domain” which is responsible for transferring 
free energy from the redox event into the more distant parts of the membrane arm, 
probably for translocation of protons. We proposed that reduction of the quinone causes 
a compensatory increase in the pKa of the key lysine in the NuoH subunit. As a result the 
first intramembrane lysine becomes protonated. Uptake of the first proton electrostati-
cally affects the pKa of the next lysine in the row, in the NuoN subunit, causing its 
deprotonation. Then electrostatic polarization is propagated even further and conse-
quently shifts the pKa of the following lysines, located in the NuoM and NuoL subunits. 
After this, the first phase of the electrostatic polarization accompanied by possible 
changes in the orientation of key lysines is completed (see above). In order to return the 
protein into the initial state, “input” state, the second phase of polarization may be 
initiated by the subunit NuoL, in which case the process proceeds in reverse direction, 
towards the “coupling domain”, and finally resultes in neutralization of the negative 
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charge of the hydroquinone anion (see below) by uptake of the second substrate proton. 
The schematic representation of the proposed principle is shown in Figure 7. 
 
Figure 7. A tentative formulation of the principle governing redox-coupled proton 
pumping in Complex I 
 
In our studies of the electron transfer kinetics in Complex I using the 
freeze-quench approach we observed full reduction of the N2 cluster, but no ubisemi-
quinone was detected. It is worth noting, that the extremely fast relaxing ubisemiquinone 
radical magnetically interacting with N2 had been detected only in submitochondrial 
particles and in the presence of high membrane potential (Ohnishi, 1998; Yano et al., 
2005). The latter condition might indicate instability of the radical and thus low redox 
potential of the Q/Q·¯ couple. If so, this may have important implications for the proton 
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translocating mechanism. Our failure to detect a signal from semireduced quinone despite 
full reduction of the N2 cluster could mean that the population of the quinone radical is 
too small to be detected. Such a low concentration of semiquinone in equilibrium with the 
reduced center N2 could indicate that the midpoint potential of the Q/Q·¯ couple is  at  
least 100 mV more negative than that of cluster N2 (i.e. less than ?300 mV) and thus 
close to the Em of NADH/NAD+ couple. In this case it may happen that the delivery of the 
first electron from NADH to ubuquinone is not accompanied by any drop of energy 
whereas the transfer of the second one occurs across a large potential drop and results in 
release of free energy sufficient to drive translocation of four protons across the 
membrane. If this is the case, then quinone should be reduced ‘virtually’ in one step to 
hydroquinone anion instead of ubisemiquinone, which would explain our failure to detect 
semiquinone radical.  
The suggested mechanism of the energy transduction by Complex I could be 
classified as direct since quinone reduction is coupled with proton translocation via 
electrostatic interactions between protonable amino acid residues and conformational 
changes that are restricted to the switching orientation of the lysines in the membrane 
dielectric towards the inside or outside of the membrane.  
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6. SUMMARY 
In the present study we applied a set of different methods to study the electron and 
proton transfer reactions in Complex I from Escherichia coli.  
We established  a  conventional  protocol  for  purification  of  the  enzyme and  de-
termined the factors, which affect the measurement of the native quinone-reductase 
activity of the enzyme. 
A significant achievement was the experiment where we monitored distribution 
of two electrons within Complex I upon reduction with NADH using an ultra-fast kinetic 
technique allowing measurement of electron transfer in the ?s time scale. We found that 
the N2 cluster is reduced in a time close to that predicted by the electron transfer theory, 
which means that the electron transfer through the chain of Fe-S clusters in Complex I is 
unlikely to be coupled to proton transfer directly or to conformational changes in the 
protein.  
 In this work we have for the first time presented redox titrations of the intact 
purified bacterial Complex I. We found that clusters N1b, N3(7), N6b, N2 and one 
tetranuclear cluster, temporarily  designated Nx, have complicated titration curves that 
could be fitted only with the sum of at least two one-electron Nernstian curves. We 
explained such behavior in terms of electrostatic repulsion between Fe-S clusters within 
the protein upon reduction under equilibrium conditions. Another manifestation of this 
phenomenon was a negative shift of the midpoint potentials of the clusters located in the 
middle of the intramolecular electron transport chain of Complex I 
We also studied the role of several conserved amino acid residues in the electron 
transfer reaction of Complex I. One of them, Glu95 from the NuoF subunit, is located in 
the NADH-binding site. We found that the negative charge of this residue is needed for 
repulsion of the product, NAD+, from the catalytic site, and thus for acceleration of the 
turnover of  Complex I. The other three amino acid residues studied, Arg274, His224 and 
His228 from the NuoCD subunit, are located in the proximity of the N2 cluster and 
quinone-binding site, respectively. We demonstrated that histidines are important for 
quinone reductase activity, but not obligatory, while the positive charge of arginine is 
critical. It is likely involved in maintaining the high redox potential of N2. 
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Finally, we found that several membrane subunits share a common pattern of 
highly conserved amino acid residues, characterized by a very prominent feature – the 
presence of a few lysines within the membrane dielectric. We probed the role of such 
lysines in the NuoM subunit and suggested they are involved in the proton translocation 
process.  Based on the experimental data, we tentatively postulated and discussed a 
principle which we think governing the redox-coupled proton pumping in Complex I. 
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